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Abstract 
Hen egg riboflavin binding protein (RfBP) acts as a source of riboflavin 
to the developing embryo. It is the most abundant vitamin binding protein in the egg 
white. Mutations giving rise to a lack of RfBP lead to embryo death at approximately 
13 days. RfBP binds riboflavin tightly in a 1: 1 ratio. On formation of this complex, 
the fluorescence of riboflavin is completely quenched; this quenching is thought to be 
due to the stacking of aromatic groups within the hydrophobic binding pocket. This 
quenching provides a convenient assay for the integrity of the riboflavin-binding site of 
the protein. 
RfBP consists of a single polypeptide chain of 219 amino acids of molecular 
mass 29.2 kDa. RfBP undergoes a number of post-translational modifications, namely: 
the formation of nine disulphide bonds, extensive glycosylation on Asn 36 and Asn 147, 
and the phosphorylation of eight serine side chains from between Ser 186 and Ser 197. 
The unfolding and refolding of RfBP was studied by denaturing in 6M 
guanidium chloride, followed by dilution in buffer, to start refolding. The processes 
were followed by both steady-state and stopped-flow circular dichroism and 
fluorescence spectroscopy. RfBP was found to readily unfold and refold, provided the 
disulphide bonds were intact. The regain of secondary structure was found to be too 
rapid to measure by the methods available (< 12 msec). The regain of tertiary structure 
was found to consist of 4 main phases, and a large proportion (80%) of the tertiary 
structure formed within 2 msec. The regain of riboflavin binding ability was complete 
at the end of the second phase, a reaction with a half-life of around 30 msec. In the 
presence and absence of riboflavin, the kinetics for the first 3 stages of tertiary structure 
changes seemed to be identical. In the presence of riboflavin, however, seemed to 
impede the completion of the final, very slow stage, with the refolding reaction only 
going to 95% completion. The dephosphorylation of the protein seemed to have no 
affect on this process. When the 9 disulphide bonds are reduced however, RfBP is 
unable to spontaneously reoxidise to a native-like state in the presence of an 
oxidised/reduced glutathione redox system. However, the addition of protein disulphide 
isomerase to the system increases significantly the yield of successfully reoxidised RfBP 
to about 50%. Attempts to prepare deglycosylated RfBP by chemical methods were 
unsuccessful since the treatment led to fragmentation of the polypeptide chain. 
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Chapterl Introduction 
1.1 Introduction 
The mechanisms involved in the production of proteins, a process fundamental to all 
living organisms, from the simplest single-celled microorganism to the blue whale, have 
been studied for many years. With the solving of the structure of DNA by Watson and 
Crick in 1953, the elucidation of the Central Dogma followed. From the transcription 
of the DNA gene sequence to the RNA template, the binding of anti-codon to codon, 
and the lengthening of the nascent polypeptide chain from the ribosome, these processes 
are well characterised and understood (Stryer, 1988). The final step in the pathway 
from DNA double helix to functioning protein, however, is not. The mechanism of 
folding a chain of amino acids into an ordered three dimensional structure, with 
biological function or activity, despite being studied for over 60 years, is still not fully 
understood. The resolution of the process of protein folding is therefore one of upmost 
importance, even if viewed from a purely academic point of view. 
In the last 20 years the molecular biology revolution and the subsequent application of 
recombinant DNA technology has transformed our world (Watson et al., 1987). With 
the potential to "cut and paste" genes from one organism to another, be it natural 
insecticides into plants, or human insulin into bacteria, it is vital that the theory behind 
folding, and also the mechanisms of the various enzymes implicated in folding in vivo 
are well characterised. Some problems have been encountered when prokaryotic 
expression machinery has to deal with the sequence for a eukaryotic protein, (especially 
if the protein is modified post-translationally, or is over-expressed, leading to 
aggregation (inclusion bodies)) (Kane and Hartley, 1988; Marston, 1986). 
Comprehension of the various processes and factors involved are therefore necessary. 
The solving of the protein folding problem will also benefit greatly other fields of 
protein research, such as structure determination. If the role of the amino acid sequence 
in dictating the final structure is known, then structure assignment shall become greatly 
simplified. In theory, knowledge of the primary structure should prove sufficient to 
predict the 3-D structure. Artificial polypeptides have been synthesised which adopt 
their predicted structure (i. e. P-barrel, helical structures) (Richardson and Richardson, 
1989). These predictions are made on the basis of the tendencies some amino acids 
have to fonn either P-sheet or cc-helix, or neither (i. e. proline is known to disrupt 
helices) (Chou and Fasman, 1978). Given the complexity of the average native protein, 
however, this prediction is not yet possible. 
The field of de novo design would also be greatly advanced. The function and scope 
of artificial proteins that could be built from scratch is almost unlimited. 
1.2 Protein folding- a history 
The history of the unfolding and refolding of proteins is almost as long as and closely 
related to, the history of protein science itself. It was the result of the denaturing of 
proteins on exposure heat, that led to the first recognition of proteins as components of 
initially food, and later biological organisms and their products (Fruton, 1972). The 
substance to which egg white owed its heat-coagulable properties to was termed 
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"albumine" by Fourcroy in 1801, and a similar substance was also to be found in blood 
serum (Fruton, 1972). Attempts to find further examples led to a variety of methods 
being employed on biological samples, thus the acid-insoluble precipitate (caseum) 
found in milk after acidification was termed casein. 
With the development of purification techniques, the coagulation process was studied 
in greater depth, and it was shown, by Chick and Martin, that the eventual precipitation 
on heating of albumin was preceded by an initial event they termed "denaturation". In 
1931, Anson and Mirsky demonstrated that the denaturation of haemoglobin, to a state 
where it could not bind oxygen, differed spectrophotometrically from the native protein, 
and could not be crystallised, could be reversed under certain conditions, i. e. renatured 
(Fruton, 1972). It was also recognised around this time that the nature of these 
processes was probably due to the expanding and contracting of polymer chains, 
although not much was known about the composition and structure of proteins at this 
time. 
The pioneer of the present day protein unfolding/refolding studies was Anfinsen, his 
studies resulting in a Nobel Prize for Chemistry in 1972. Shortly after Sanger had 
deduced the amino acid sequence of insulin, and thereby shown that the basic structure 
of a protein was a chain of amino acids of a unique sequence, Anfinsen showed that an 
unfolded protein could be refolded (Epstein et al., 1963). This refolding led to the 
complete regain of biological activity, in the absence of any other factors, in vitro, thus 
demonstrating that the 3-D structure and conformation of a protein is determined solely 
by its amino acid sequence. He also speculated that "helper" proteins were present in 
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vivo, to aid the process. The role of chaperone proteins e. g. GroEL and BiP, and 
folding catalysts, such as protein disulphide isomerase (PDI) (discovered by Anfinsen's 
group in 1964) (Givol et aL 1964) and peptidyl proline cis1trans isomerase (PPI) (Fischer 
et al., 1984) is recognised today, and although much of the practical work on folding 
involves "foldases", their mode of action, and the nature of interactions with their 
substrates, and also with other chaperones is far from completely understood. 
1.3 The protein folding problem 
Early proposals for the mechanism driving the folding event were largely based on 
thermodynamic considerations, namely that the protein molecule in its native folded 
state represented the global minimum energy state (Anfinsen, 1973). In 1969, however, 
Levinthal calculated that there are vastly too many possible conformations, even for a 
relatively short peptide chain, for folding to be a purely random search to attain this 
energy minimum, given that folding has to occur on a physiological time-scale (Zwanzig 
et al., 1992). In fact, it has been estimated that for a polypeptide of 100 amino. acids, 
it would take approximately 1066 years to sample all the possible conformations (10'9) 
(Creighton, 1994). Yet many proteins do fold readily, on a far smaller, biological 
timescale (msec-sec) (Tsong, 1976). To resolve this paradox, it was proposed that 
proteins fold via specific pathways, Le the process is under kinetic control (Creighton, 
1994a). Much of the work over the last 25 years has been directed towards identifying 
intermediates in such a pathway. Such intermediates are, by their very nature, transient, 
and their detection and characterisation has proved far from easy, but techniques such 
as pulsed hydrogen exchange, stopped flow CD etc, have been used to detect 
intermediates with specific secondary structures (Dobson et al., 1992). However, the 
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refolding of simple, small proteins has been clearly shown to be under thermodynamic 
control- the unfolded and native state exist in thermodynamic equilibrium within the 
unfolding transition, with no evidence for intermediates. (Schmid, 1992). 
Current theories ascribe to a combination of thermodynamic and kinetic control, a 
modification of the "jigsaw" theory of Harrison and Durbin (1985). They suggested that 
the folding process was analogous to completing a jigsaw puzzle- there is no set pattern 
or pathway, but folding can start anywhere, and follow innumerable pathways to reach 
the final point. The discovery of intermediates with specific secondary structure has led 
to the theory that early kinetic control (perhaps involving multiple pathways) of 
refolding produces a state in which the number of possible conformations which the 
refolding polypeptide would have to search through is significantly reduced, so the final 
structure can be attained in a physiologically reasonable time-scale (ýali ef al., 1994). 
1.3.1 Folding in vitro vs. in vivo 
Due to the myriad of macromolecules found in the cell, much of the research into 
protein folding is carried out in vitro (Freedman, 1992). Thus a homogenous population 
of protein molecules can be studied, under conditions which are easily altered 
(temperature, pH etc). One of the possible drawbacks of studying protein folding in 
vitro, is that the refolding involves a mature protein, the completed polypeptide chain, 
rather than the folding of a newly synthesised chain in vivo (Freedman, 1992). As well 
as the obvious differences between the two systems, the question of when folding 
actually begins in vivo has to be addressed, to gauge whether the study of refolding 
mature proteins is a valid model for the in vivo folding process, i. e. is folding co- 
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translational, or does it commence after the completion of the polypeptide chain? 
Since most proteins are capable of refolding from a denatured state in vivo, it is fair to 
assume that folding does not depend on the initial presence of the N-terminal to prompt 
cooperative folding i. e. it is not controlled by the vectorial nature of translation 
(Freedman, 1992). There have also been examples of slightly truncated polypeptide 
chains being unable to refold- if 6 amino acids are removed from the C-terminal of 
BPTI, the protein is unable to refold and reoxidise, after reductive denaturation 
(Taniuchi, 1970; Andria and Taniuchi, 1978). Similarly, the removal of several C- 
terminal amino acids from staphylococcal nuclease severely perturbs the structure of the 
protein (Shortle and Meeker, 1989). A compact structure is fon-ned, but it lacks native 
secondary and tertiary structure. 
The question of additional cellular factors must also be addressed. In the test tube, 
refolding generally starts with a homogenous unfolded protein sample (in the random 
coil state, with a virtually limitless number of possible conformations), and a denaturing 
agent, such as Gdn HCL The cell, on the other hand, would contain a myriad of 
molecules, native and folding proteins, chaperones, "foldases" etc, possibly acting in 
conjunction, as well as a host of other molecules unconnected with the protein folding 
processes. Although there is an apparent gulf between the two scenarios that has in the 
past caused doubt to be raised on the validity of studying the refolding of completed 
polypeptides in vitro, it has been shown that there are grounds for using such studies 
at least for small single domain proteins (Freedman, 1992). Furthermore, in the past 
decade, the use of chaperones and enzymes such as PDI and PPI in vitro, have 
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demonstrated the insights that in vitro refolding can give to the cellular process. 
1.4 Egg white proteins 
The egg white, or albumen, is formed by tubular glands found around the developing 
oocyte, during its passage through the oviduct, prior to the deposition of the shell by the 
shell gland (White and Merrill, 1988). In a typical hen egg, the white comprises 
roughly 60% of the volume, and contains approximately 50% of the total egg protein 
(Gilbert, 1971). This volume decreases as the embryo develops, over the three week 
incubation period, till at hatching none remains. Proteins are a major component of egg 
white, up to 10.5% by weight (Gilbert, 1971). A small amount of egg protein is used 
as an energy source for the developing embryo, but most of the protein present in the 
egg is converted into body protein by hatching. This would suggest that egg protein is 
mainly present as an amino acid reservoir for the embryonic chick. However, the 
conserved amino acid sequences of the egg white proteins characterised indicate 
otherwise (Stevens, 1991), as conserved sequences would indicate conserved structures, 
and hence function. 
Although there are thought to be over forty proteins present in the albumen, only about 
a quarter of these have been well characterised. Egg white proteins have often been the 
focus of protein biochemists, especially in the early days of the discipline, mainly due 
their ready availability, the quantities present, and their ease of separation. Indeed many 
important discoveries and advances have been made through the study of egg white 
7 
proteins. The first atomic resolution three dimensional structure was derived from 
lysozyme, which led to the proposal of its catalytic mechanism (Phillips, 1967; Imoto 
et al., 1972; Hammes, 1982). Introns, non-coding sequences within genes, were first 
found in ovalburnin (the most abundant egg white protein) (Breathnach, 1977), and the 
affinity of avidin for biotin is one of the strongest, specific ligand binding reactions 
known, a feature which has been exploited by biotechnologists, e. g in affinity 
chromatography and drug delivery (Stevens, 1991). Somewhat surprisingly though, the 
exact biological functions for most of the proteins in the albumen, other than a purely 
nutritional role, has yet to be ascertained. A summary of the postulated roles of some 
of the egg white proteins is given in Table 1.1 (adapted from Stevens, 1996). 
As can be seen in Table 1, the majority of the egg white proteins appear to have an 
anti-bacterial/microbial role (Stevens, 1996). This is obviously very important to the 
developing embryo, in the absence of an comprehensive immunological system in the 
enclosed space of the egg (although a small amount of immunoglobulin, IgY, is 
present). As well as being a nutritional source for the chick, the proteins, vitamins and 
carbohydrate found in the white, are also just as useful a source of nutrition to bacteria 
and other microorganisms, but evolution has provided adequate defences against such 
attack. A number of ploys are utilised to this effect. The first barrier (after the shell) 
is the viscosity of the albumen, thickest at the shell due to ovornucin, which also 
protects against mechanical shock. A range of protease inhibitors exist, with different 
specificities, and in addition lysozyme degrades bacterial cell wall peptidoglycans. 
Finally the vitamin binding proteins are thought to act in this role as scavengers of free 
vitamins, denying them for microbial usage. The vitamin binding proteins are known 
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Table 1.1 : Main egg white proteins, and their possible roles 
Protein Abundance (% of albumen) Possible-role 
Ovalbumin 54% Metal ion binder/ 
protease inhibitor 
Ovotransferrin 12% Iron (III) binder 
Ovomucoid 11% Protease inhibitor 
Lysozyme 3.4% Anti-bacterial 
Ovomucin 1.5% Increases viscosity 
Riboflavin binding 0.8% Anti-microbial/ 
protein riboflavin transport 
Immunoglobulin (IgY) 0.8% Antibody 
Ovostatin 0.5% Protease inhibitor 
Avidin 0.06% Binds biotin/anti- 
microbial 
Cystatin 0.05% Protease inhibitor 
Thiamine binding protein trace Binds thiamine 
(adapted from Stevens, 1996) 
to have another role, that of vitamin transport to the developing chick. Of these proteins 
the most abundant is riboflavin binding protein (Stevens, 1991). 
1.5 Riboflavin binding protein 
The biosynthetic pathways producing most vitamins were lost to the distant ancestors 
of vertebrates (White and Merrill, 1988). As a result mechanisms were developed to 
facilitate the uptake of the dietary vitamins, from the intestine and serum. To supply 
the developing embryo with riboflavin (vitamin 132). vertebrates possess high affinity 
riboflavin binding proteins, which carry riboflavin to the appropriate area. While 
mammals can continuously supply the embryo with nutrients, avians, and other egg- 
laying species have to accumulate all the nutrients required for development prior to egg 
deposition. The riboflavin required for avian embryos is found in the yolk. The egg 
white of hens and their closer relatives is unique, in that it has a yellow tinge, due to 
riboflavin bound to RfBP. Other birds have egg white RfBP, but without bound 
riboflavin, and reptiles have neither RfBP or riboflavin in their egg white (White and 
Merrill, 1988). In the early 1950's, a commercial poultry breeder in Pennsylvania 
noticed that 3 otherwise healthy hens were laying fertilised eggs, which never hatched 
(White, 1990). Further study revealed that the embryos died at 13 days, and that these 
eggs lacked the characteristic yellow tinge found in normal egg whites. These hcns 
were brought to the attention of Maw at Pennsylvania State University, who quickly 
concluded that the embryos were dying due to riboflavin deficiency, associated with a 
genetic flaw, and that they could only be rescued by directly injecting the eggs with 
riboflavin, which made it possible to perpetuate the mutant strain (White and Merrill, 
1988; White, 1990). 
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In 1965, it was shown that the mutant hens lacked riboflavin binding protein, and that 
the uptake of dietary riboflavin was limited by the amount of Rfl3P present (Winter et 
al, 1967). More recently, it has been demonstrated that cDNA from the riboflavin 
deficient mutants has a 100 nucleotide sequence deletion in the messenger RNA. This 
was found to coffespond to a complete exon from the RfBP gene missing, due to a G-ýA 
mutation at position I of the downstream 5' splice site, causing the loss of RfBP 
(MacLachlan et A, 1993). 
In 1966, Blum produced a model for the uptake of riboflavin in laying hens. tie had 
isolated RfBP from serum, and concluded that it was virtually identical to tile RfBPs 
already purified from egg white and yolk (see White and Merrill, 1988, and references 
therein). He proposed that the serum RfBP, synthesised in the liver, forms a complex 
with dietary riboflavin in the blood stream. This is then transported to the yolk. It is 
now thought that this transport occurs via a "piggyback" method, where RfBP binds to 
vitellogenin, which then crosses the vitellin membrane by a 95 kDa receptor protein 
(MacLachlan et A, 1994). Upon entry to the yolk, a 13 residue peptide is cleaved from 
the C-terminal portion of RfBP by cathepsin D (Stevens, 1996). 
Hen egg white riboflavin is synthesised in the oviduct. Although yolk RfBP is 
associated with riboflavin transport, it is thought that hen egg white riboflavin is 
primarily concerned with anti-microbial activity, through the scavenging of free 
riboflavin. Hen egg white contains holo-RfBP, but the RfBP present is not saturated. 
Indeed, it has been found that if apo-RfBP is injected into the eggs of rd recessive hens 
(RfBP negative mutants), the minute amount of riboflavin present is bound by the RfBP, 
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thus denying it to the embryo, which dies at an even earlier stage (2 days, as opposed 
to 13 for untreated rdrd embryos) (Lee and White, 1995). 
1.5.1 Structure of RfBP 
White, yolk and serum RfBP are all products of the same gene, with minor tissue 
specific differences in their post-translational modifications (White and Merrill, 1988). 
The protein is globular, monomeric and there is no evidence for separate domains. The 
primary structure has been deduced from direct amino acid sequencing (flamazurne et 
A, 1984) and from cDNA sequencing (Zheng, 1988), and consists of 219 amino acids 
(fig 1.1). The N-terminal residue is pyroglutarnic acid, and polymorphism can occur at 
residue 14, where 30-50% of molecules have lysine instead of asparagine (11amazurne 
et al, 1984; Norioka, 1985). 
RfBP is a phosphoglycoprotein (Rhodes et al, 1959; Miller et al, 1982). From the 
amino acid sequence, carbohydrate and phosphate composition, the total molecular mass 
is 29.2 Kda (Harnazurne et al., 1984). This is less than the value of 30-36kDa 
suggested from other methods (SDS PAGE, sedimentation equilibrium, etc) (see White 
and Merrill, 1988, and references therein). This discrepancy is probably due to the 
bulky carbohydrate groups present. Molecular weights of glycoproteins are also oftcn 
over-estimated by SDS PAGE (Hamazume et al., 1984 ). The isoclectric point of RfBP 
is about 4.0 (Rhodes et al., 1959). There is, as yet, no 3-D structural information 
available for RfBP. Crystals that diffract to 2.8 A have been obtained, but these proved 
unsatisfactory for structure determination (Zanette et al., 1984). 
CHO 
15 
219 
Figure 1.1 The primary structure of riboflavin binding Z". 4ý protein (CHO- carbohydrate, P- phosphate) 
(from Hamazume et al., 1987) 
1.5.2 Post-translational modifications of RfBP 
RfBP undergoes a number of post-translational modifications, namely phosphorylation, 
glycosylation, disulphicle bond formation and limited proteolysis (liamazume et al., 
1984). RfBP has 8 phosphorylated serines (Rhodes et al., 1959, Miller et al., 1982). 
These are thought to be involved with serum RfBP uptake to the yolk (Miller et al.. 
1982). These are present in a highly anionic region between residues 186 and 199 
which, in the egg white protein also includes five glutarnate and one methionine residues 
(Hamazume et al., 1984). The main differences between the egg white and yolk serum 
proteins are in the structure and composition of the carbohydrate (Miller el al., 1982a) 
. RfBP is extensively disulphicle bonded, with 9 disulphicle bridges (Kozik, 1982a). 
Limited proteolysis also occurs; the nucleotide sequence predicts an N-terminal 17 
residue signal pepticle and two arginine residues at the C-terminus, not observed in the 
mature protein (MacLachlan, 1993). 
1.5.3 Riboflavin binding and the binding site of R11111 
Apo-RfBP binds riboflavin very tightly (Kd' "": 1.3 x 10-9 M), in a 1: 1 ratio (Bevcar and 
Palmer, 1982). The avidin-biotin binding system (also found in egg white) is one of the 
few ligand binding systems with a lower Kd9 itself only surpassed in strength by a few 
metal ligand binding proteins. Binding studies with flavin derivatives (FMN, FAD, etc) 
show that RfBP can bind other similar molecules, but not as strongly as riboflavin 
(Rhodes et al., 1959; Bevcar and Palmer, 1982). These studies have shown that 
although no one part of the molecule is essential, the 7- and 8-methyl groups and the 
2'-hydroxyl group contribute significantly to binding, while the hydroxyl groups on the 
N-10 side chain are thought to form hydrogen bonds with the protein in a tight cavity 
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(Choi and McCormick, 1980). The binding pocket is thought to form a hydrophobic 
cleft. One each of the six tryptophan and nine tyrosine residues have been shown to be 
essential for binding, through chemical modification studies (Blankenhorn, 1978). The 
tryptophan is not protected against chemical modification by bound riboflavin. and 
therefore could be near the hydrophobic binding pocket, while the tyrosine is protected, 
and probably lies within the binding site. Bound riboflavin prevents inactivation by 
carbodiimide, suggesting the presence of a carboxyl group at the binding site (Kozik, 
1982). 
An interesting feature of the binding system, is that upon the binding of riboflavin by 
the apo-protein, the fluorescence of riboflavin is completely quenched (Rhodes, 1959). 
This feature is thought to be due to a stacking interaction between riboflavin and a 
aromatic base at or near the binding site, most probably tryptophan (Choi and 
McCormick, 1980). 
1.5.4 RfBP as a model system for studies of protein folding 
There are a number of reasons why RfBP makes a good model in the study of in vitro 
protein folding. The protein is easily purified, in fairly large quantities. At 29.2 kDa, 
it is of a reasonable size. Other well studied refolding systems, have been smaller, Le 
BPTI, and lysozyme, are 6.5 and 14.3 kDa respectively, and contain fewer disulphide 
bonds (Jaenicke, 1987). The extensive post-translational modification undcrgone by 
RfBP (disulphide formation, glycosylation and phosphorylation) also offer scope for 
study- what role do these modifications play in the folding/rcfolding pathway? The 
quenching of riboflavin fluorescence upon binding to the apo-protein also provides a 
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convenient assay of biological activity. 
1.6 Previous work 
In preliminary work on the unfolding and refolding of RfBP, Allen et al. (1992) 
demonstrated that, provided the disulphide bonds remained intact, the protein could be 
refolded from its denatured form with high efficiency, when dialysis was used to remove 
the denaturing agent (Gdn HCI). In conditions under which the disulphide bonds in 
RfBP were broken and kept reduced, the unfolding of RfBP by Gdn IICI could not be 
reversed by subsequent dialysis. 
1.7 Aims of the project 
The main aims of the project were to : 
i)To purify riboflavin binding protein from hen egg white. 
ii)Characterise the refolding of denatured 
RfBP. 
iii)To assess the effect of the numerous post- 
translational modifications on the refolding 
process. 
iv)To assess the significance of the results in 
relation to models for protein folding. 
14 
Chapter 2 Methods 
2.1 Absorbance spectroscopy 
All single wavelength absorbance measurements were made on a LKB Biochrom 
Ultraspec Il spectrophotometer, using a quartz I cm pathlength cuvette of capacity I ml, 
and the appropriate buffer as a reference blank. The absorption spectra were recorded 
on a Jasco V-550 UVNIS dual beam spectrophotometer, using matched quartz I ml/ I 
cm pathlength cuvettes. 
2.2 Circular dichroism 
2.2.1 Steady-state circular dichroism 
Steady-state far UV circular dichroism (CD) spectra (260-190 nm) were recorded on a 
Jasco J-600 spectropolarimeter, using cylindrical quartz cells of pathlengths 0.02 cm, 
0.05 cm or 0.1 cm, depending on the concentration of the protein. Generally, spectra 
were recorded over the 260-190 nm range. Refolding studies measured the changes in 
the ellipticity at 225 nrn against time. 
2.2.2 Stopped-flow circular dichroism 
Stopped-flow far UV CD studies were carried out on an Applied Photophysics SX- 
17MV Stopped-Flow Reaction Analyser instrument, using the umbilical ccll in the 0.2 
cm pathicngth position. Unless otherwise stated, the mixing was in a 10: 1 ratio (i. e. II- 
fold dilution) of protein in 6M Gdn HCI. 
Refolding studies measured the change in ellipticity at 230 nm against time. 230 nm 
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was chosen as opposed to 225 nm, as reproducible results could only be obtained at 230 
nm and above; at lower wavelengths the signal to noise ratio was considerably worse. 
2.3 Fluorescence spectroscopy 
2.3.1 Steady-state fluorescence 
Fluorescence studies were recorded on a Perkin-Elmer LS-50B spectrofluorimeter in a 
Iml cuvette of I cm pathlength, at 20T. For protein fluorescence, the excitation 
wavelength was 290 nm, and the emission spectra were recorded over the range 300-400 
nm. For riboflavin fluorescence studies, the excitation wavelength was 370 nm, with 
the emission recorded at 520 nm. 
In the case of the refolding protein, the emission at 350 nm (with excitation at 290 nm) 
was measured against time (up to 2 hours). The quenching of riboflavin fluorescence 
by the refolding protein was measured by recording the emission at 520 nrn (with 
excitation at 370 nm), against time. Slit widths were tYpically 5 nm +5 nm bandpass, 
but were adjusted to cater for different for protein/riboflavin concentrations. 
2.3.2 Stopped-flow fluorescence 
Fluorescence stopped-flow studies were recorded on the SX-17MV instrument, at 20T. 
Protein refolding was recorded by emission at 350 nm (with excitation at 290 nm), 
against time. Quenching of riboflavin fluorescence was recorded at 520 nm (with 
excitation at 370 nm), against time. All slit widths were typically I mm, but were 
adjusted to cater for different protein/riboflavin concentrations. Unless otherwise stated, 
mixing was in a 10: 1 ratio. 
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2.4 SDS-PAGE 
Polyacrylamide gel electrophoresis was utilised, according to the modified discontinuous 
system of Laemmli (1970). The Bio-rad "Mini-Protean" II dual slab cell system was 
used. 
The solutions, and volumes, used in the preparation of mini-gels can be seen in Table 
2.1. Samples were diluted 1: 1 with 2x sample buffer containing 2 gl 2- 
mercaptoethanol/ml and boiled for 2 minutes. 10% of the sample volume of a 1: 1 
mixture of 1% bromophenol blue and 2-mercaptoethanol was added to the sample. 
Typically, 30 gl of sample was loaded per lane with a Hamilton syringe. 150 V was 
applied across the apparatus until the bromophenol blue band was 0.5 cm from the 
bottom of the gel. The gel was placed in the stain solution for 30 min, then the destain 
solution for 2 hours, with several changes of solution. 
2.4.1 Molecular mass markers 
Dalton Mark VII molecular mass markers (purchased from Sigma) were used to estimate 
the molecular mass of proteins on the gel, by comparison of the relative distance of 
migration with the markers of known molecular masses. The marker proteins and thcir 
molecular masses are listed below: 
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Marker Protein Subunit 
Mr 
Bovine serum albumin 66000 
Ovalbumin 45000 
Glyceraldehyde-3 -phosphate dehydrogenase (rabbit) 36000 
Bovine carbonic anhydrase 29000 
Soybean trypsin inhibitor 20000 
(x-Lactalbumin 14200 
2.5 Preparation of ribonavin stock solution 
Riboflavin (0.1 mg/ml) was partially dissolved in buffer (0.05 M sodium phosphate, 
pH6.8), and stirred vigorously for 30 min. The solution was then filtered twice, through 
Whatman No. I filter paper. The stock solution was stored in the dark at 4'C. Fresh 
stock solutions were prepared monthly. 
2.6 Estimation of RfBP and riboflavin concentration 
The concentrations of RfBP and riboflavin were determined by measuring tile 
absorbances at 282 nm and 455 nm respectively and using the published extinction 
coefficients (Nishikimi and Kyogoku, 1973; Miller and White, 1986). The value for 
apo-RfBP at 282nm is 49000 M-'cnf' , and for riboflavin at 455nm, 12500 M*lcm". 
2.7 Riboflavin fluorescence quenching assay 
0.9ml of a riboflavin solution of known concentration was placed in a cuvette in the 
fluorimeter, and the fluorescence emission at 520 nm, with excitation at 370 nm, was 
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recorded. 10 gl aliquots of an apo-RfBP solution, ten times more concentrated than the 
riboflavin (on a molecular basis), were added, the solution mixed well, and the 
fluorescence recorded as before, until the addition of RfBP had no further effect on the 
riboflavin fluorescence. 
2.8 Preparation of guanidinium chloride solution 
Gdn HCI solutions were made up by weight and the concentration was verified by 
measuring the refractive index of the solution (Nozaki, 1972). After correction for 
buffer, an 8M solution of Gdn HCl has a refractive index increment of 0.132. 
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Chapter 3 Purification and Characterisation of RfBl' 
3.1 Introduction 
Riboflavin binding protein (RfBP) was first isolated in 1958, by Rhodes and co-workers, 
who were fractionating egg white proteins using the new method of carboxymethyl- 
cellulose ion-exchange chromatography (Rhodes et al., 1958). As well as providing 
higher yields of greater purity of the main known egg white proteins than traditional 
methods, they reported a previously unknown flavoprotein. The flavin moiety was 
found to be riboflavin. They proceeded to characterise the flavoprotein, which they 
termed riboflavin binding protein (Rhodes et al., 1959) 
The purification method used in this project is largely based on that by which Rhodes 
et al. (1958) first isolated the protein. A DEAE Sephadex column (anion exchange) is 
first used to isolated and purify the holo-protein. The apo-protein is purified by means 
of a CM Sephadex column (cation exchange). At pH 3.8, the holo-protein binds to the 
column, but the riboflavin dissociates from RfBP, leaving the apo-protein (Section 
3.2.1). 
RfBP has been isolated from a wide variety of sources (Walker et al., 1991; 
Visweswariah et al., 1987; Krishamurthy el al., 1984) from avian and reptilian eggs to 
pregnant mammals, including humans, although the hen egg white protein is probably 
the most widely studied, due to its availability and ease of purification. 
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3.1.1 Spectroscopic analysis 
Several methods are available to study the conformation of proteins. Obviously, those 
which can produce a high resolution 3-dimensional picture of the protein are the most 
useful, but the techniques which are capable of this, NMR spectrometry and X-ray 
crystallography, require large amounts of protein (tens of milligrams) and a lengthy 
time-scale, possibly extending to years in the case of X-ray crystallography (Price, 
1995). Both techniques have limitations; thus NMR is limited to smaller protein 
molecules up to about 25 kDa, while not all proteins will give crystals of a suitable size 
and quality necessary for diffraction studies. Spectroscopic methods, especially circular 
dichroism and fluorescence spectroscopy, on the other hand, provide reasonable, if less 
detailed structural information in a short time (less than 30 minutes). and require very 
little sample (100 gg of protein, or less) (Price, 1995). Due to the short time scale 
involved in data acquisition, further enhanced with the development of rapid mixing 
techniques (stopped-flow), it is even possible to record real-time structural changes 
within the molecule. 
Circular dichroism (CD) involves the differential absorption of left and right circularly 
polarised components of plane polarised radiation, when a chromophore is chiral, or it 
has been placed in a chiral environment (Freifelder 1982, Price, 1995). Radiation is 
split into two circularly polarized components, by being passed through a modulator, 
such as a piezoelectric crystal, which is subject to an alternating electrical field. If the 
two components are not absorbed by the sample, or are absorbed by the same amount, 
then no CD signal will be produced. If, however, if one of the polarized componcnts 
is absorbed to a greater extent than the other (e. g. due to the intrinsic or environmcntal 
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chirality of a chromophore), then the resulting radiation would be elliptically polarised, 
i. e. instead of a plane, an ellipse will be traced out. In practice the 2 components are 
not recombined after passage through the sample- the machine actually measures the 
change in absorbance. The term ellipticity (referring to the theoretical recombination) 
is widely used. From this degree of ellipticity, it is possible to relate the signal obtained 
to structural information, i. e. the relative proportions of (x-helix and P-sheet can be 
determined from signals obtained in the far UV which arise from the peptide bonds. 
Protein fluorescence is used as a measure of protein tertiary structure. Fluorescence 
occurs when a molecule is excited by radiation. The molecule then decays from its 
excited state, and the excess energy is released, at a higher wavelength. Protein 
fluorescence is largely due to the excitation of aromatic amino acid residues, particularly 
tryptophan, which has a maximum emission at 356 nm, after excitation at 290 nin 
(Harris, 1987). Burial within a protein, or shielding by other amino acid residues, will 
lead to a blue-shift in wavelength, thus revealing information on the location of these 
residues. The quenching of protein fluorescence, i. e. after ligand binding, can also 
reveal information on the active site, or the mechanism of action of the protein. During 
refolding studies, the regain of protein fluorescence can be used as an indicator as to tile 
extent of regain of tertiary structure, given that the unfolded protein will have a 
maximum emission of 356 nm, which will shift to the blue on folding, as the tryptophan 
residues become buried or sheltered within the protein. With RfBP, the quenching of 
riboflavin fluorescence upon binding to the apo-protein (Rhodes el al., 1959) is also 
useful, as an assay for the viability of the protein, i. e after refolding or reoxidation 
(Allen et aL, 1992; Kozik, 1982a). 
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3.2. Methods 
3.2.1 Purification of holo-RfBP 
The purification schedule was based on that of Rhodes el al. (1958), with sonic 
modifications (Walker et al., 1991) The whites of 12 eggs were separated by hand and 
pooled (approx. volume 400 ml). They were then homogenised, adjusted to pli 5 with 
glacial acetic acid, and spun in a Beckman GPR bench centrifuge for 15 min at 3000 
g. The supernatant was then added to Sephadex A-50 (0.4 g per 100 ml of supernatant, 
pre-swollen in 0.05 M sodium acetate buffer, pH 5, for 3 hours), stirred once and left 
on ice for one hour. The gel was poured into a 10 x3 cm glass column, and washed 
through with buffer (0.05 M sodium acetate, pH 5) until the A280 was less than 0.1. The 
column was then washed successively with buffer containing 0.05,0.1 and 0.15 M 
NaCl, each time till the A2,, was less than 0.1. Buffer containing 0.5 M NaCl was then 
applied to the column, and the eluted yellow RfBP collected in 10 ml fractions with a 
fraction collector. The absorbance of the fractions at 280 and 455 nm was measured, 
and those with an A45. j above 0.02 were pooled and dialysed extensively against buffcr. 
The A-50 column was washed with buffer containing IM NaCl (500 ml), then buffer 
(500 ml). The dialysed sample was loaded back on to DEAE A-50 column, and washed 
with the series of salt buffers as before. Following elution with 0.5 M NaCl buffer as 
before, the protein was dialysed against buffer. 
3.2.2 Preparation of apo-RfBP 
The pH of the sample was adjusted to 3.8. The sample was then loaded onto a2x 10 
cm SP Sephadex C-50 column, previously equilibrated to pfi 3.8. The column was 
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washed with 0.05 M sodium phosphate buffer, pH 3.8, until the yellow colour 
(riboflavin) was removed from the column, the bound protein forming an opaque white 
band, and the A455 was negligible (<0.005). The bound apo-protein was eluted with 0.1 
M sodium acetate, pH 4, buffer containing 0.5 M NaCl, and collected in 5 ml fractions. 
These were dialysed against sodium phosphate buffer (0.05 M, pH 6.8) and the volume 
reduced approximately 8-fold by dialysis against 60% PEG. The protein was then 
freeze-dried, and resuspended to give a stock solution of the desired concentration 
(normally 10 mg/ml), in a final sodium phosphate buffer (pH 6.8) concentration of 0.05 
M. 
3.3 Characterisation of RfBP 
The homogeneity and binding ability of the purified protein were assessed by SDS- 
PAGE (Section 2.4) (Laemmli, 1970) and a riboflavin fluorescence quenching assay 
(Section 2.7). Samples taken during the purification procedure were also analysed via 
SDS-PAGE. The absorbance, CD and fluorescence spectra of RfBP were recorded as 
described previously (Sections 2.1,2.2.1,2.3.1. ) (the protein concentration was 0.1 
mg/ml in each case). 
3.4 Results 
3.4.1 SDS PAGE 
SDS PAGE analysis of samples (Section 2.4) taken at various points throughout the 
purification procedure showed the first DEAE-Sephadex column removed most of the 
unwanted protein, and the second column yielded pure holo-RfBP. The final SP 
Sephadex C-50 column was efficient in removing riboflavin from the holo-protein, to 
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RfBP, from 12 eggs. 
3.4.2 Binding of riboflavin 
The purified protein was found to bind riboflavin in a 1: 1 ratio (Fig. 3.1), consistent 
with previous results. (Rhodes et al., 1959; Allen et al., 1992) The quenching was 
found to be linear with the concentration of RfBP, indicating tight binding (the Kd has 
been estimated to be 1.3 x 10" M (Bevcar and Palmer, 1982)). 
3.4.3 Spectroscopic analysis 
The absorption spectrum of 0.26 mg/ml RFBP (Fig. 3.2) showed that the absorbance 
peaked at 282 nm. The CD spectra (Fig. 3.3) of the holo- and apo-protein were almost 
identical, consistent with previous results (Allen et al., 1992; Kumosinski et al., 1982, 
Nishikimi and Kyogoku, 1973). The CONTIN secondary structure analysis program 
was applied to the CD spectra of apo-RfBP (Provencher and G16ckner, 1981). This 
analysis predicted the protein to contain 38% a-helix and 32% fl-sheet. The protein 
fluorescence spectrum (Fig. 3.4) of the holo-protein, compared with that of apo-RfBP, 
showed a marked reduction on the intensity of fluorescence, by approximately 75 %. 
The wavelength of maximum emission is also shifted slightly to the blue on formation 
of the holo-protein complex, from 345 nm to 343 nm (Fig. 3.4). 
3.5 Discussion 
The purification of RfBP from hen egg white was successful. Although 60mg was the 
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The purification of RfBP from hen egg white was successful. Although 60mg was the 
average amount obtained from 12 eggs, on several occasions, nearly twice that amount 
was obtained. It was noted on these occasions that the egg white (after separation from 
the yolk) was much more intensely yellow. The reason for this is unclear, as it has 
been reported that, unlike some other egg white proteins, the abundance of RfBP is 
generally consistent. 
RfBP was shown to bind riboflavin in a 1: 1 ratio, above pH 4. Below this and the 
riboflavin dissociates from the protein, probably due to the disruption of hydrophobic 
interactions between the flavin molecule and the hydrophobic binding site. A wide 
range of riboflavin analogues have been shown to be able to bind to RfBP, indicating 
that no single part of the riboflavin molecule is essential for binding, although the 
pyrimicloid side of the flavin ring appears to play no part in the binding and is thought 
to be exposed to the solvent (Rhodes et al., 1959; Choi and McCormick, 1980; Bevcar 
and Palmer, 1982)(Fig. 3.5). The two methyl groups on the dimethylbenzenoid portion 
are thought to be involved in hydrophobic interactions with the protein, while the 
hydroxyl groups on the N' chain form hydrogen bonds with the protein, ensuring the 
tight binding of the flavin. 
The complete quenching of riboflavin fluorescence upon binding to RfBP was noted. 
This is thought to be due to a ground-state stacking interaction between riboflavin and 
the tryptophan residue found in the binding site (through protection studies) 
(Blankenhorn, 1978). This would also account for the quenching of approximately 80% 
of the intrinsic protein fluorescence on riboflavin binding, and also the decrease in the 
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maximum emission wavelength, as solvent accessibility of the tryptophan at or near the 
binding site was reduced. 
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Chapter 4 Unfolding and Refolding of RfBP 
4.1 Introduction 
The unfolding and refolding of oxidised RfBP was studied in vitro in order to 
characterise the folding process for this protein, and to provide a basis for understanding 
the folding process in vivo. Several methods of unfolding were tested, in order to find 
the most suitable for RfBP. The apo-protein was denatured and refolded in the presence 
and absence of riboflavin. The conformational state of the protein was ascertained via 
spectroscopy (CD and fluorescence) and binding ability. The kinetics of the folding 
reaction were determined using steady state and stopped-flow instrumentation. The use 
of ANS as a structural probe for the refolding process was also studied. 
4.1.1 The study of unfolding and refolding proteins 
The study of protein folding generally involves trying to understand the process by 
which a fully unfolded protein (U), matures into the folded native state (N), and 
identifying any intermediates that may lie between the 2 states (Creighton, 1993; 
Radford et al., 1992; Bycroft et al. 1990). When unfolded, the protein is said to exhibit 
a random coil conformation (Tanford, 1968). The molecule resembles a randomly 
twisting chain with an essentially limitless number of conformations, although in 
practice, steric and spatial considerations, such as bond angles and degrees of rotation 
will reduce these (i. e. two residues cannot occupy the same space at the same time). 
None-the-less, it is plausible for every molecule in an average sample to have a different 
conformation at this stage (Creighton, 1993). This structure exhibits no stable secondary 
or tertiary structure, although there is some evidence for very short lived, fluctuating 
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elements of secondary structure (Murray-Brelier and Goldberg, 1989). 
The fully folded structure is obviously the state of the native protein, exhibiting native 
secondary, tertiary (and quaternary if applicable) structure, and native biological activity, 
if relevant, Le catalysis, binding activity etc. What is of greatest importance to those 
workers interested in protein folding is, what lies between these two states, and by what 
means the random coil is converted to a folded compact molecule. 
The molten globule has been postulated as an important intermediate in the protein 
folding "pathway" (Ohgushi and Wada, 1983). This is a state where the protein is 
reasonably compact, has native, or near-native secondary structure, but non-native, 
fluctuating tertiary structure. Molten globule formation is thought to occur early in the 
folding process of many proteins, as a result of a rapid hydrophobic collapse of the 
polypeptide chain (Mann and Matthews, 1993; Jones et al., 1995). 
8-anilino-l-naphthalene-sulfonate (ANS) is a commonly used probe for the molten 
globule state of proteins (Ptitsyn et al., 1990; Sernisotnov et al., 1991). ANS binds to 
hydrophobic sites in proteins and the fluid tertiary structure of the molten globule 
provides many possible such sites. As the tertiary structure becomes more native-like, 
however, these sites/environments disappear, and ANS is released. As the fluorescence 
of ANS is markedly enhanced only upon molten globule binding, the increase and decay 
of ANS fluorescence has been used as probe for the transient molten globule state 
(Ptitsyn, 1992). 
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Several methods are available to unfold proteins in vitro, including changes of pH, heat 
and the use of chaotropic agents such as guanidinium chloride (Gdn HCI) and urea 
(Price and Stevens, 1989). Most proteins will rapidly denature in 6M Gdn HCI, and 
so this is probably the most widely used method, although features of the certain 
proteins mean that the other methods can be used Le a cold labile protein, unfolded by 
low temperature, could be refolded by return to an ambient temperature (Williams et al.. 
1996; N61ting et al., 1995). After denaturation in high concentrations of Gdn HCI, the 
polypeptide chain resembles a random coil, whereas proteins denatured by thermal or 
pH means have sometimes been shown still to have some secondary structure present. 
(Matthews, 1993), In the case of denaturing or chaotropic agents, the concentration of 
the agent can be reduced by dilution, to a level where little, or no, effect is seen on the 
protein. After denaturation, it is found that most small monomeric globular proteins will 
refold to a biologically active state spontaneously on return to suitable conditions. 
4.1.2 Monitoring the Unfolding and Refolding Process 
A number of methods are available to follow the unfolding and refolding of proteins. 
As previously discussed (Section 3.1.1), CD and protein fluorescence spectroscopy are 
powerful tools for analysing the conformations of proteins. The speed of data 
acquisition (especially with stopped-flow apparatus) means that the actual unfolding or 
refolding process can be followed by recording the change in CD/fluorescence signal 
at a certain wavelength as a function of time. Additionally, if the biological activity (eg 
binding of ligand, conversion of substrate to product) of the protein involves a 
spectroscopic change, the regain of this property can be followed. With RfBP, for 
example, the regain of riboflavin binding activity can be measured by recording the 
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fluorescence of riboflavin in the presence of the refolding protein. As the refolding C, 
protein regains activity, the riboflavin fluorescence is quenched. 
4.2 Methods 
4.2.1 Unfolding of apo-RfBP 
4.2.1.1 Guanidinium chloride denaturation 
An 8M solution of guanidine hydrochloride was prepared and the concentration 
confirmed as described previously (Sections 2.8). Samples containing 0.1 mg/ml RfBP 
and Gdn HCI concentrations ranging from 0-6 M were prepared and incubated at 20T 
for 15 minutes. The CD and fluorescence spectra were recorded for each sample as 
previously described (Sections 2.2.1,2.3.1). 
4.2.1.2 Urea denaturation 
A 10 M solution of urea was prepared. Samples containing 0.1 mg/ml RfBP and urea 
concentrations ranging from 0-9 M were prepared and incubated for 15 minutes. The 
fluorescence spectrum was recorded for each sample as previously described (Section 
2.3.1). 
4.2.1.3 pH denaturation 
A series of sodium phosphate buffers, from approximately pH 7-pH I were made up by 
titrating sodium phosphate with either NaOH or H3PO4. Apo-RfBP was added to a 
concentration of 0.1 mg/ml, and incubated for 15 minutes. The fluorescence spectrum 
was recorded for each sample as previously described (Section 2.3.1). 
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4.2.1.4 The effect of Gdn HCI on the structure and activity of RfBP 
RfBP was incubated with Gdn HCI (0-6 M), for 15 mins at room temperature. Each 
sample was then subjected to CD and fluorescence analysis (Sections 2.2.1,2.3.1) A 
riboflavin binding assay was then performed for each sample (Section 2.7) 
4.2.2 Refolding of apo-RfBP 
The protein was denatured, as described in 4.2.1.1, by mixing protein solution at an 
initial concentration of 10 mg/ml with 8M Gdn HCI, to give a Gdn HCI concentration 
of 6 M, and incubated for 15 minutes. Refolding was initiated by dilution of the sample 
with buffer to reduce the Gdn FICI concentration. Dilution was carried out either 
manually or by stopped-flow mixing. 
CD, protein fluorescence and riboflavin fluorescence were all recorded at the 
appropriate wavelengths as a function of time, as described in Chapter 2. 
Experiments concerning the regain of secondary and tertiary structure during refolding 
were duplicated in the presence of an equirnolar concentration of riboflavin. 
With manual mixing (steady state), the final Gdn HCI concentration was 0.1 M, and for 
stopped-flow mixing, 0.54 M. The limit of 0.54 M was imposed on the stopped flow 
by the 1: 10 mixing syringe setup employed. These concentrations of denaturant have 
a very minor effect on the protein, and do not affect binding of riboflavin. 
To determine the start and end points of the refolding reactions, the 
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Table 4.1: X 
n=j and relative 
intensity of fluorescence spectra of RfB P at X .., at 
various pH levels. 
pH X max 
(nm) 
Intensity 
(arbitary units) 
7.06 346.6 366 
6.08 346.4 342 
4.91 346.4 348 
4.06 346.6 358 
3.12 347.9 408 
2.15 346.4 358 
L12 
345.7 266 
Table 4.2: X MX, and relative fluorescence intensity at 
X 
.., 
from 
fluorescence spectra of Rfl3P in 0-9 M urea 
[Urea] 
(M) 
?I 
max 
(nm) 
Intensity 
(arbitary units) 
0 346.2 396 
1 346.4 396 
3 347.9 445 
5 348.9 505 
7 352.3 795 
9 354.2 977 
Table 4.3: X maxt and relative 
fluorescence intensity at ?. from 
fluorescence spectra in 0-6 M Gdn HCI 
[Gdn HCl] 
(M) 
X. 
(nm) 
Intensity 
(arbitary units) 
0 345 189 
1 345 209 
2 347 263 
3 350 313 
4 352 322 
5 353 330 
6 356 384 
e 
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Figure 4.1 Changes in the fluorescence of REBP after 
incubation with 0-6 M Gdn HCI 
(excitation at 290nm) 
e 
elipticity/fluorescence intensity of RfBP were measured after incubation in 6M Gdn 
HCI (start point) and either 0.1 M or 0.54 M Gdn HCI (endpoint), depending on the 
instrument used (steady state or stopped-flow). 
4.2.3. ANS as a probe for structural changes in RfBP 
Denatured RfBP was refolded as before, in the presence of 20 gM ANS, and the 
fluorescence of ANS measured (excitation 370 nm, emission 480 nm), to test for the 
presence of a molten globule intermediate, through the enhancement of ANS 
fluorescence on binding to such a species. The reaction was studied with both steady 
state and stopped-flow instrumentation. The interactions between ANS and native RfBP 
was also investigated i. e. whether RfBP can bind ANS, and how the refolding process 
and riboflavin binding are affected by ANS. 
4.3 Results 
4.3.1 Unfolding of apo-RiBP 
4.3.1.1 Fluorescence studies on various methods of denaturation 
Tables 4.1,4.2 and 4.3 show the wavelengths of maximum emission (X ma,, ), and the 
relative intensities at each maximum. Figure 4.1 shows the fluorescence spectra 
recorded from denaturations involving increasing concentrations of Gdn HCI. 
From a comparison of the three methods of unfolding tested, only Gdn HCl appears to 
be capable of unfolding RfBP completely. The value of kn,,,, is the main indicator here- 
tryptophan has aX of 356 nm- therefore if the fluorescence spectrum of the protein has 
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max of 356 nm, then the tryptophans are considered fully exposed to the solvent 
(Harris, 1987). 
The low pH has very little effect on the tertiary structure of RfBP, as can be seen in 
Table 4.1. The X max is not affected 
by the pH, even as low as pH 1. In contrast, urea, 
especially at the higher concentrations, is more effective in RfBP denaturation, but at 
9M urea, the protein still has some residual tertiary structure, as the X max 
is 354.5 nm, 
not 356 nm as would be expected if the protein was fully unfolded (Table 4.2). This 
can be seen in the presence of 6M Gdn HCI (X a,, = 356 nm), 
indicating that Gdn HCI 
is the best denaturant for RfBP of those tested (Table 4.3, Fig. 4.1). 
4.3.1.2 Steady state CD and fluorescence analysis of RfBP after Gdn HCl 
denaturation 
In agreement with the results of Allen et al. (1992), apo-RfBP appeared to be fully 
denatured after incubation in 6M Gdn HCI; there was a total loss of secondary and 
tertiary structure and the riboflavin binding activity was lost (Figs. 4.2,4.1 and 4-3). 
In 6M Gdn HCI, the wavelength of maximum fluorescence emission is identical to that 
of tryptophan model compounds (356 nm), indicating complete exposure of tryptophan 
residues to the aqueous environment. Similarly, the CD spectrum above 205 nm (a 
lower limit imposed by the absorbance of Gdn HCI) of the protein in 6M Gdn HCI is 
indicative of a random coil. This unfolding occurred despite the retention of the nine 
disulphicle bonds in the protein. In agreement with the earlier data (Allen et al. 1992), 
the fluorescence and CD signal changes indicated that the unfolding was not a simple 
two-state process; a first change occurs between 0M and 2M Gdn HCI and a second 
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Figure 4.2 Changes in the CD spectrum of RfBP after 
incubation in 0-6 M Gdn HCI 
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Fig 4.3: The effect of Gdn HCI on the binding of riboflavin by nc R: flBP 
0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 
between 5M and 6M Gdn HCI (Fig. 4.4). There appears be an intermediate state of 0 
RfBP stable between 2M and 4M Gdn HCI. 
4.3.2 Refolding of denatured RfBP (steady state analysis) 
4.3.2.1 Changes in CD 
The rate of regain of secondary structure of RfBP during refolding was examined by far 
UV CD. It was found that the changes in the elipticity of the protein at 225 nm were 
complete within 10-15 s, the "dead time" of this type of manual mixing experiment. 
It was also shown that the presence of an equirnolar concentration of riboflavin had no 
significant effect on the rate of changes in the far UV CD on refolding. These results 
indicated that the formation of native secondary structure during refolding was rapid. 
4.3.2.2 Changes in protein fluorescence 
The changes in protein fluorescence appeared to be at least biphasic. In the absence of 
riboflavin, 95% of the refolding (i. e. of the total fluorescence change) occurred within 
50 seconds. This was followed by a slower phase, lasting up to 2 hours, in which the 
final 5% of the fluorescence change occurred (Fig. 4.5). 
In the presence of equimolar riboflavin, only 90% of the tertiary structure was regained 
after the initial rapid phase, and a further 5% of the total change expected (i. e. the 
difference between RfBP in 6M Gdn HCI and RfBP in 0.1 M Gdn HCI) occurred over 
the subsequent 2 hours (Fig. 4.6). 
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Figure 4.5 Refolding of REBP - fluorescence emission at 
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Figure 4.6 Refolding of RMP - fluorescence emission at 
350mn following dilution of Gdn HCI, in the 
presence of equimolar riboflavin 
The slower phase, seen in both the presence and absence of riboflavin, could be 
indicative of some of the slower steps thought to be involved in protein folding, such 
as cisltrans isomerisation of X-Pro pepticle bonds (Lang et al., 1987). The results also 
seem to imply that the presence of riboflavin in some way slightly impedes the 
acquisition of the final native tertiary structure; this point is discussed later (Section 
4.4). 
4.3.2.3 Time course of riboflavin fluorescence quenching 
In the riboflavin fluorescence quenching experiment, the native RfBP quenches the 
riboflavin fluorescence almost immediately, while the refolding Rfl3P takes almost 200 
seconds to reach an endpoint, although the main part (> 90%) of the process is complete 
within 10 seconds (the 'dead time'of the experiment) (Fig. 4.7). 
4.3.2.4 Summary of steady state analysis 
From a combination of steady state fluorescence and CD studies, therefore, it would 
appear that the refolding denatured RfBP regains all of its secondary structure, and most 
of its tertiary structure, within a few seconds of the start of the refolding process, largely 
within the dead-time of the steady state instruments, approximately 10 seconds. 
The completion of the regain of native tertiary structure took somewhat longer, up to 
one hour for the final 5%, in the absence of riboflavin. For a more detailed insight into 
the early stages of the folding process in which most of the structural changes occur, 
stopped-flow CD and fluorescence techniques were employed. 
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Figure 4.7 Regain of riboflavin binding ability - fluorescence 
emission at 520 nrn following dilution of Gdn 
HCI (arrow marks dilution) 
4.3.2.5 Refolding of denatured RfBP (stopped-flow analysis) 
4.3.2.6 Changes in stopped-now CD 
The regain of secondary structure, as measured by the regain of CD signal at 230 nrn 
was found to be complete within the dead-time of the stopped-flow instrument, which 
has been estimated to be approximately 12 msec (see Appendix 1). It was also shown 
that the presence of an equirnolar concentration of riboflavin had no significant effect 
on the extent and rate of the changes in the far UV CD on refolding. 
4.3.2.7 Changes in protein fluorescence 
A total of 4 phases of fluorescence during the refolding were resolved, namely- very 
fast, fast, slow and very slow (Figs. 4.5,4.8,4.9). Most (80%) of the fluorescence 
change again occurred in the dead-time of the instrument, estimated to be 1.7 msec 
(Appendix 1). The rates and half-times of the first three phases were calculated by the 
stopped-flow instrument's internal kinetic analysis software, while the half time of the 
the very slow phase was estimated from the steady state fluorimeter results (Table 4.4). 
In the presence of riboflavin the kinetics of the 4 phases of protein fluorescence regain 
were identical to that of the refolding apo-protein, when the extra amplitude 
(approximately 80%) due to the quenching of the protein fluorescence by riboflavin was 
taken into account (Figs. 4.8,4.9). 
4.3.2.8 The regain of ribollavin binding activity 
The regain of riboflavin binding activity was measured through the fluorescence change 
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at 520 nm upon the addition of native and denatured (refolding) RfBP (Fig. 4.10). The 
binding of riboflavin by the native protein is very rapid (t,, = 3.5 msec). The regain of 
binding ability in the refolding protein was found to have similar kinetics to the fast 
phase found in tertiary structure acquisition (t,, = 30 msec), indicating that the binding 
pocket is formed during this stage. 
4.3.3 ANS binding 
The binding of 20 gM ANS to apo-RfBP (8 gM), resulted in a 20 fold increase in ANS 
fluorescence (Fig. 4.11). The intrinsic fluorescence of Rfl3P was quenched by 
approximately 50%, and the %,,,. slightly blue shifted, from 346 to 343 nm (Fig. 4.12). 
An equivalent enhancement of protein fluorescence quench and shift was found when 
the experiment was repeated with the holo-protein (Fig. 4.13) and the enhancement in 
ANS was identical to that found with the apo-protein. The apo-RfBP/ANS complex was 
able to bind, and quench the fluorescence of, riboflavin (Fig. 4.14). Although the 
denatured RfBP was unable to bind ANS, the ability to bind ANS was regained (as 
judged by the increase in ANS fluorescence) by the refolding protein within the dead- 
time of the instrument, i. e. before the regain of riboflavin binding ability (< 2 msec). 
The presence of ANS during refolding did not affect the ability of the refolded protein 
to bind riboflavin. The kinetics of refolding (Fig. 4.15), and riboflavin binding (Fig. 
4.16), as measured on the stopped-flow instrument, were not affected by the presence 
of ANS. 
4.4 Discussion 
In spite of having nine disulphide bridges, RfBP appears to lose all detectable secondary 
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Table 4.4 Tle regain of tertiary structure in refolding RfBP 
V. fast Fast Slow V. slow 
Half- time <I msec 30 msec 46s 60 min 
% of total change 80 10 5 5 
and tertiary structure after incubation in 6M Gdn HCJ. This is analogous to the 
behaviour of another disulphide bonded protein, lysozyme (Dobson et al., 1994). The 
tertiary structure of RfBP was largely resistant to acidic pH, probably as a result of the 
stability conferred on the protein by the extensive disulphide bonding. 
As long as the nine disulphide bonds remain intact, denatured RfBP was found to refold 
completely and very quickly after the removal of the denaturing agent, without the need 
for any other additional agents such as chaperone proteins. From the stopped-flow and 
steady state data, it is apparent that the refolding process occurs in several stages. The 
results show that all of the native secondary structure and a large proportion of the 
native tertiary structure are formed very quickly after the initiation of refolding, within 
the dead-times of the respective instrument modes. This is analogous to other systems 
studied e. g. lysozyme, cytochrome c (Dobson et al., 1994; E16ve et al., 1992). This 
could indicate that the protein structure formed during the very fast phase was similar 
to a molten globule, a compact, condensed molecule, with large elements of native 
secondary structure, but fluctuating tertiary structure. However, ANS binding studies 
did not follow the expected classic pattern of rapid binding, followed by slow release, 
an indicator of the formation and disappearance of a molten globule state (Ptitsyn, 
1992). The pattern of ANS binding does, however, shed additional light on the 
refolding process. The native apo- and holo-proteins were both able to bind ANS, as 
is the case for a number of other proteins in their native state e. g. glutamate 
dehydrogenase and creatine kinase (Dodd and Radda, 1969; McLaughlin, 1974). During 
refolding, the protein regained the ability to bind ANS more quickly than the ability to 
bind riboflavin. It has been suggested that the presence of ANS from the start of 
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refolding can perturb the folding process, leading to the formation of ANS dependent 
kinetics and intermediate states (Engelhard and Evans, 1995). However the kinetics of 
the refolding reaction of RfBP as monitored by changes in protein fluoresence were not 
affected by the presence of ANS, nor was the riboflavin binding ability of the refolded 
RfBP. ANS tends to bind to clustered hydrophobic residues, so it might be expected 
that the hydrophobic riboflavin binding site could be a candidate for an ANS binding 
site. However, as the holo-protein can bind ANS, in a similar manner to the apo- 
protein, it is clear that the ANS is binding at a site, or sites, distinct from the riboflavin 
binding pocket. It is perhaps not surprising that refolding RfBP regains the ability to 
bind ANS long before riboflavin binding ability. The riboflavin binding site (Fig. 3.5) 
is thought to be a structured hydrophobic pocket, which binds riboflavin very tightly, 
indicating strong specific interactions between Rfl3P and riboflavin. ANS, on the other 
hand, only requires a non-specific, non-structured hydrophobic environment to bind to. 
One or more areas possessing such an environment could easily be rapidly formed 
following the initiation of refolding. 
The quenching of riboflavin fluorescence by the native apo-protein is very fast (t, = 3.5 
msec), which is consistent with association rate constants for enzymes and substrates 
(Fersht, 1985). The regain of riboflavin binding ability coincides with the second phase 
of fluorescence regain (t, ý 30 msec), indicating that the refolding protein has assumed 
near native tertiary structure at this point. The third (slow) phase presumably reflects 
further small changes in the tertiary structure. The final regain of native tertiary 
structure can take up to two hours. This slow phase could reflect the cis1trans 
isomerisation of X-Pro bonds (Lang et aL, 1987). To verify this, a high resolution 
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structure of the protein would be needed, to determine the conformation of the 8 proline 
residues. The enzyme peptidyl prolyl isomerase could also be tested as a catalyst for 
this step in the folding of RfBP (Schbnbrunner et al., 1991). 
It would appear that the presence of riboflavin during the refolding process somehow 
impeded the final acquisition of tertiary structure, albeit very slightly, and this had no 
effect on the binding of riboflavin. It could be that the binding pocket, or the riboflavin 
binding element, is formed relatively early in the refolding process, and the binding of 
riboflavin at this stage places constraints on small adjustments in the local tertiary 
structure. 
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Chapter 5 Reduction and Reoxidation of RfBP 
5.1 Introduction 
One of the most important factors involved in maintaining the specific three dimensional 
structure of a protein is the disulphide bond. This covalent link, formed by the 
oxidation of 2 cysteine side chains to form a cystine residue, adds greatly to the stability 
of a structure (Creighton, 1993). 
The formation of disulphide bonds also has implications for protein folding. In Chapter 
4, the refolding of the unfolded, oxidised RfBP was studied, i. e. the disulphicle bonds 
were intact. Even though the molecule had all the characteristics of a random coil, as 
ascertained by CD (no discernable secondary structure), the existence of 9 covalent links 
in a molecule must limit the number of possible conformations accessible to it. It has 
also been demonstrated that the formation of disulphide bonds can occur co- 
translationally (Bergman and Kuehl, 1979; Peters and Davidson, 1982), and as such, 
must place considerable restrictions of the flexibility and possible conformations of the 
nascent polypeptide chain, again restricting the structural possibilities open to it. 
Therefore, although valuable insights into the mechanism of folding can be gained from 
the study of refolding of oxidised molecules, it is important to study the formation of 
disulphide bonds during the folding process, in order to gain appropriate insights into 
the folding process in vivo. 
42 
5.1.2 Disulphide bonds in RfBP 
RfBP is extensively disulphide bonded, containing 9 disulphide bridges (Fig. 1.1). It 
is undoubtedly these bonds which give RfBP its great stability - solutions of the protein 
can be boiled for 30 minutes (Rhodes et al. 1959), with no loss of activity and the 
protein does not denature until the temperature has reached 130'C (White and Merrill, 
1988). All nine disulphide bonds appear to be of equal reactivitY toward reducing 
agents: however the holoprotein appears to be more resistant to reduction than the 
apoprotein (Allen et al., 1992). It has been proposed that destroying one of the 
disulphide bonds will disrupt riboflavin binding (Kozik, 1982a). This disulphide is not 
protected by riboflavin, and so is thought to lie outside the binding pocket. 
5.1.3 Protein disulphide isomerase 
Protein disulphide isomerase (PDI) (EC 5.3.4.1) was first described as a "general and 
non-specific catalyst for disulphide interchange in proteins containing disulphide bonds" 
over thirty years ago. It was discovered by Anfinsen and his co-workers (Goldberger 
et al., 1963), who had postulated the existence of additional factors assisting in vivo 
folding when they demonstrated that the amino acid sequence contained all the 
information neccessary for the folding of a polypeptide chain into a mature protein. 
Some structural characterisation of PDI was also carried out at the time, but the enzyme 
was largely ignored until the 1980's. Since then, however, a number of studies have 
confirmed the location, action and role of PDI in the cell, thus verifying that PDI is 
responsible for the formation/isomerisation of disulphide bonds during the folding of 
proteins (Freedman et al., 1989; Freedman, 1992). 
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5.1.3.1 Structure of PDI 
PDI is found in the lumen of the endoplasmic reticulurn (ER)(Freedman, 1989). It is 
very abundant, accounting for approximately 0.4% of the total cellular protein (Hillson 
et al., 1984). Its concentration may be in the millimolar range (Gilbert, 1989). PDI 
is active as a homodimer (M,, 110000), with no interchain disulphide bonds (Freedman 
et al., 1984). The major parts of the sequence are widely conserved across eukaryotes, 
and it has a prokaryotic counterpart in DsbA, which is found in the periplasm of 
bacteria; plant homologues have also been found (Freedman et al., 1994). The 
monomer of PDI consists of 6 domains ( a, a', b, b, c and e). A and a' are 47% 
identical, and have been shown to be homologous to thioredoxin, a small ubiquitous 
protein, involved in many cytoplasmic redox reactions (Freedman et al., 1994). The 
active site of PDI is structurally homologous to that of thioredoxin, and consists of a 
short loop containing the sequence -CGHC-. The two Cys residues have been clearly 
implicated as the redox active sites of catalysis, by mutagenesis and chemical studies. 
The two domains of PDI can function independently (Freedman et al. 1994). 
The exact mode of action of the enzyme in its disulphide formation/isomerisation role 
has not yet been clarified; such studies are hampered by the size of the PDI molecule, 
and of the substrate, and the complexity of the reaction catalysed (Freedman et al., 
1994). It is thought that PDI generates disulphicle bonds that "permit the most stable 
folded conformation of the system as a whole at the applied thiol/disulphide redox 
potential" (Freedman, 1992). PDI has an extremely wide substrate range (potentially 
all proteins containing disulphide bonds). 
44 
5.1.3.2 Other roles for PDI 
PDI has been shown to be a multifunctional enzyme, and has been found to be present 
as a subunit of other complex multienzyme systems. Prolyl-4-hydroxylase catalyses the 
formation of 4-hydroxyprolyl residues in nascent collagen-like polypeptides. The 
protein is a tetramer, with an cýP2 subunit structure. It was known for some years that 
many cells contained an large excess of P-subunits, and that newly synthesised a 
subunits recruited P subunits from this pool - later studies showed that the P-subunits 
are in fact PDL the pool corresponding to the free PDI of the lumen (Koivu et al., 
1987). The role of PDI in this instance appears to be to ensure the solubility and 
integrity of the native complex; when expressed in the absence of PDI in a cell-free 
expression system, the cc-subunits aggregate. The Cys residues implicated in disulphide 
formation/isomerisation are not involved in this role of the enzyme (Vuori et al., 1992). 
PDI is also the D-subunit of triacylglycerol transfer protein. This protein incorporates 
lipids into newly synthesised core lipoproteins in the ER. Similarly to P4H, the protein 
exhibits no PDI-Iike activity, but upon dissociation of the dimer, the (x-subunits 
aggregate, and soluble PDI activity returns (Wetterau et al., 1990). 
A number of other functions have been ascribed to PDI. It exhibits affinity for thyroid 
hormones, and has been studied as a thyroid-binding protein. It has also been shown 
to have an affinity for peptides, including glycosylatable peptides (Noiva and Lennarz, 
1992). It has also been suggested that PDI may act in a general chaperone role, 
assisting folding and preventing aggregation within the ER (Noiva and Lennarz, 1992). 
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5.1.3.3 In vitro use of PDI 
A number of studies have investigated the effects of PDI on the refolding of reduced 
unfolded proteins (Lyles and Gilbert, 1991, Lille et al., 1994; Wunderlich et al., 1995). 
Lilie et al. (1994) used an antibody Fab fragment as a substrate. PDI has been 
implicated with the folding of Fab in vivo, since covalently linked complexes of PDI 
and nascent antibody light chains have been isolated from cells (Roth and Pierce, 1987). 
Lille et al. (1994) found that although PDI had no affect on the rate of refolding of the 
oxidised protein (i. e. no chaperone activity), the rate of reoxidation of the reduced 
protein was increased approximately 10-fold. 
5.2 Methods 
5.2.1 Reduction of RfBP 
Apo-RfBP was reduced by the method of Kozik (1982a). All buffers and solutions 
contained 2.7 mM EDTA and were freshly purged with 02-free nitrogen for 2 minutes 
to minimise random reoxidation by atmospheric oxygen, catalysed by trace metals. I 
ml of aI mg/ml RfBP solution was incubated overnight in 8M urea and I mM DTT 
at room temperature. 
The reduced RfBP was separated from excess urea and DTT by gel filtration on 
Sephadex G-25. The elution buffer (50 mM sodium phosphate, p1l 7.8) contained I 
mM GSH, to prevent reoxidation of the reduced RfBP. The sulphydryl content of 
reduced RfBP was determined spectrophotometrically by reaction with NbS2 (Ellman. 
1959) using a sample which had been rapidly gel filtered in the absence of GSH. The 
CD and fluorescence spectra of the reduced RfBP were recorded. 
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5.2.2 Estimation of free sulphydryl groups 
NbS2, (Ellman's reagent) is widely used for assaying free thiol groups. It reacts with 
thiol groups to liberate one mole of 2-nitro-5-thiobenzoate per mole of thiol groups. 
This molecule has an intense yellow colour, and its formation can be monitored 
spectrophotometrically at 412 nm (Ellman, 1959). 
5.2.3 Reoxidation of reduced RfBP 
Reoxidation was initiated by the addition of GSSG to a final concentration of 0.1 mM. 
This ratio of [GSH]/[GSSG] (1/0.1) was found to be the optimum through reoxidation 
studies. The extent of regain of the native structure of RfBP was assessed by measuring 
the quenching of riboflavin fluorescence (as described in Section 2.7) of samples taken 
from the reoxidation mixtures, over periods up to five days. 
5.2.4 The effect of PDI on the reoxidation of RfBP 
When the effect of PDI was being studied, PDI was added to the solution of reduced 
RfBP in GSH immediately prior to the addition of GSSG . This order of addition was 
found to be essential. A series of reactions were set up, with increasing PDI: RfBP 
molar ratios, from 1: 2 up to a maximum of 5: 1. The reoxidation reactions were 
performed at 4'C. Control experiments were performed with equivalent molar ratios of 
BSA in place of PDI, to verify that the successful reoxidation did not arise from a 
general protein/protein interaction. Control experiments showed that the presence of 
PDI or BSA did not interfere with the measurement of riboflavin binding. 
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PDI was purified from bovine liver by the method of Freedman et al. (1995), and was 
generously supplied by Stephen McLaughlin, University of Kent. 
5.3 Results 
5.3.1 Reduction and reoxidation of apo-RfBP 
After reduction of apo-RfBP in denaturing conditions (the urea partially unfolds the 
protein, allowing the DTT access to internal buried disulphide bonds), and gel filtration 
to remove excess DTT and urea, reaction with NbS2revealed a sulphydryl content of 20 
±3 per molecule RfBP, in reasonable agreement with the value of 18 expected from the 
primary structure of the protein. The CD spectrum of the reduced protein was identical 
to that previously published (Allen et al., 1992) (Fig. 5.1). The wavelength of 
fluorescence emission maximum was 349 nm (Fig. 5.2). Previous work had suggested 
that the emission maximum of the reduced species was 354 nm (Allen et al., 1992). It 
is possible that the reduction method employed by Allen et al. (involving NaBH4)may 
lead to more extensive denaturation of the reduced protein. The CONTIN secondary 
structure analysis program was applied to the CD spectrum of reduced RfBP 
(Provencher and Gl6ckner, 198 1). It predicted an decrease in the level of (x-helix, from 
38 % to 24 %. From these studies it is clear that reduced RfBP has a lower content of 
secondary structure and more highly exposed tryptophan side chains than native RfBP, 
but still retains some folded structure. 
The reduced RfBP was unable to bind riboflavin, as shown by the failure of the reduced 
RfBP to quench riboflavin fluorescence (Fig. 5.3). Control experiments showed that the 
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presence of GSH and or GSSG at the concentrations used in these studies had no effect 
on the binding properties of native oxidised RfBP (results not shown). Treatment of the 
reduced apo-RfBP with GSI-I/GSSG alone led to complete oxidation of the sulphydryl 
groups, as shown by the lack of reaction with NbS2, after dialysis to remove excess GSH 
and GSSG. The overall structural properties of the reoxidised RfBP as measured by CD 
and fluorescence showed wide variations between material obtained in replicate 
experiments, presumably indicating that formation of a specific set of disulphide bonds 
had not occurred. 
The regain of binding activity during reoxidation is expressed as a percentage of the 
quenching of riboflavin fluorescence observed with a control sample of native RfBP of 
similar concentration to the reoxidising RfBP (0.04 mg/ml) incubated at 4'C in the 
GSH/GSSG mixture for an identical period of time. Less than 5% quenching was 
observed with the reoxidised RfBP, indicating that no significant binding ability had 
been regained. 
The effect of inclusion of PDI during the reoxidation was studied. It was found that 
reproducible data could onlY be obtained if all buffers were flushed with 0, -ftee 
nitrogen for 2 min immediately prior to the reoxidation experiments. It was also found 
that recovery of activity was higher at 40C than at 20T, and increased with increasing 
concentrations of PDL Under the optimum conditions explored (i. e. a5 fold molar ratio 
of PDI added to RfBP prior to addition of GSSG at 4'Q approximately 45% of the 
binding ability of native apo-RfBP could be regained (Fig. 5.4). In contrast, a 
maximum of 4.5% recovery was achieved with the GSII/GSSG redox system in the 
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absence of PDI. At lower molar ratios of PDI: RfBP, lower degrees of recovery of 
activity were observed (Fig. 5.4). Addition of BSA to reoxidising RfBP in place of PDI 
yielded no active protein (Fig. 5.4), indicating that the effect of PDI is specific and does 
not represent a general chaperone-type action. In agreement with the studies of Lilie 
et al. (1994) on the refolding of reduced Fab, it was found that the effect of PDI is very 
dependent on the time of addition of PDI to the reoxiclation mixture, with yields of 
reactivation being decreased substantially if the PDI is not present at the start of the 
reoxidation (i. e. if the PDI was added after the GSSG, used to initiate the reoxidation). 
Because of the presence of large amounts of PDI, it was not possible to measure the 
structural properties of the reoxidised RfBP by spectroscopic methods. 
5.4 Discussion 
While the oxidised denatured protein would readily refold upon the removal of the 
denaturant, it was found that the reduced denatured molecule (disulphide bonds broken) 
was unable to refold spontaneously to the native state, on dilution of the denaturant, 
under oxidative conditions. 
The extent of formation of the correct disulphide bonds during the reoxidation of 
reduced RfBP was clearly greatly enhanced by the presence of PDI. The use of PDI 
in reoxidation experiments increased the yield of correctly reoxidised RfBP by at least 
10-fold to a value approaching 50%. These findings are similar to those reported by 
Lilie et al. (1994), who found that PDI, in molar concentrations comparable with or 
50 
greater than those of reduced Fab, increased successful reoxidation of the protein. 
Optimum regain of activity was obtained when the PDI: RfBP ratio was 5: 1. Given that 
the concentration of PDI in the lumen of the endoplasmic reticulum is thought to be in 
the millimolar range, the relatively high concentration of PDI required to achieve a high 
yield of reactivation is not surprising. The time period needed for maximum reoxidation 
(approx. 3 days) is perhaps indicative of the method of action of PDI in this manner in 
vitro, which appears to be the reshuffling of incorrectly formed disulphide bridges into 
the correct native links. The rate limiting step in this process could reflect the rate at 
which non-native links become accessible to PDI (McClelland et al., 1995). In the case 
of RfBP, with 9 disulphide bonds, it is extremely unlikely that every incorrectly formed 
such bond is accessible to the action of PDI at any one time. The slow rate of 
reoxidation could reflect (i) the need for the protein to unfold, at least partially, in order 
to allow access to the PDI, and/or (ii) the very large number of combinations of 
incorrectly formed disulphide bonds which PDI would have to shuffle, in order to reach 
the native forrn - 19 free sulphide groups can theoretically form over 34 million 
disulphides. Although in practice this number will be reduced due to steric and spatial 
considerations, the number of possible combinations will still be vast. 
Even the presence of PDI from the very start of the reoxidising process does not 
facilitate the formation of the correct disulphides in anything approaching the 
physiological time scale, i. e mill iseconds-seconds. Therefore, while PDI is undoubtedly 
a useful too] in vitro for enhancing yields in the reoxidation of reduced proteins by the 
'shuffling' of incorrectly fonned disulphides, it is clear that its role in vivo can only be 
understood in the context of the other processes and factors which are involved in the 
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production of correctly folded proteins. It is thought that in vivo at least some of the 
disulphide bonds are formed co-translationally, and that some initial folding/secondary 
structure formation occurs within the nascent polypeptide chain (Bergman and Kuehl, 
1979; Peters and Davidson, 1982). It is possible that various chaperone proteins found 
in the lumen of the ER interact with the folding protein chain and these could bring 
pairs of sulphydryl groups into juxtaposition so that the correct disulphides are formed 
in a co-translational manner by the action of PDI. It has been suggested that in RfBP, 
the breaking of only one (unidentified) disulphide bond can lead to the loss of the 
binding activity of the protein (Kozik, 1982a). In the reverse process correct formation 
of this single bond could possibly have a crucial effect on the subsequent formation of 
the correct disulphide bonds within the molecule. The action of PDI in this putative 
role in vivo would obviously be much quicker than its isomerisation function in this 
type of experiment. 
It can be seen therefore that the conditions under which the in vitro reoxidation process 
involving the completed polypeptide chain is studied are different from those which 
pertain to the biosynthesis of the protein. In vivo, disulphide bond formation may occur 
as the polypeptide chain is growing and forming localised structural elements, and 
additional components such as chaperone proteins are present. However, given that the 
oxidation of reduced RfBP to give reasonable yields of active protein can be achieved 
in the presence of PDI, albeit on a greatly retarded time scale, it is reasonable to suggest 
that studies such as this can give important insights into the interplay between protein 
folding and disulphide bond formation in secreted proteins. This is particularly true for 
those proteins (such as RfBP) where reoxidation of the reduced proteins using mixtures 
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of GSH and GSSG alone gives very poor yields of active material. 
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Chapter 6 Dephosphorylation of RfBP 
6.1 Introduction 
Phosphorylation is the most common reversible covalent post-translational modification 
undergone by proteins (Darby and Creighton, 1993). It involves the substitution of an 
amino acid side chain by a phosphate group. Serine, threonine and tyrosine are the 
most commonly phosphorylated residues, but aspartic acid, histidine and lysine can also 
be modified. The reaction can be catalysed by residue specific and non-specific kinases 
(Creighton, 1993). 
The reversible phosphorylation of proteins and enzymes by kinases and phosphatases 
plays a number of important roles including cellular control, regulation and transport 
(Stryer, 1988). The phosphorylation or dephosphorylation of enzymes can act as a 
switch, turning on the activity of that enzyme, which in turn can similarly modify 
another molecule, often resulting in a cascade of activation. For example, skeletal 
muscle phosphorylase exists in two interconvertible forms, a and b. The dimeric, 
inactive phosphorylase b is converted to active phosphorylase a upon the 
phosphorylation of serine 14 in each subunit (Stryer, 1988). This reaction is catalysed 
by phosphorylase kinase, itself regulated by phosphorylation (Stryer, 1988). 
Phosphorylation can also act as a marker for protein targeting. The formation of a 
mannose 6-phosphate residue by a phosphotransferase is vital for the targeting of 
glycoproteins from the Golgi to the lysosome (Stryer, 1988). 
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6.1.2 Phosphorylation of apo-RfBP 
Egg white apo-RfBP contains 8 phosphorylated serine residues (Rhodes ef al., 1959, 
Miller et al., 1982). These are situated in a very anionic region between residues 186 
and 199 that also contains five glutarnates and one methionine residue (Fig. 1.1) 
(Hamazume et al., 1984). 
Dephosphorylation of RfBP was first reported by the group who first isolated and 
purified RfBP from hen egg white (Rhodes et aL, 1959). Potato acid phosphatase was 
used, and 95% dephosphorylation was reported. It was found that dephosphorylation 
had no effect on the binding of riboflavin by the protein. More recently, in vivo studies 
involving the partial dephosphorylation of yolk RfBP have demonstrated that tile 
removal of just one phosphate decreases uptake from the serum to the yolk (by 60 %), 
and subsequent dephosphorylation further decreases uptake (Miller et al., 1982). 
Studies have shown that the native protein can bind calcium phosphate and form cross 
links with other RfBP molecules, but this property is greatly impaired on 
dephosphorylation (Aoki et aL, 1993). In the past, the search for a specific receptor for 
serum RfBP, to facilitate uptake into the yolk proved fruitless (White and Merrill, 
1988). However, recent studies have shown that RfBP can form a complex with 
vitellogenin in the presence of calcium phosphate (MacLachlan et al., 1994). It is 
thought that RfBP utilises the uptake of vitellogenin by the 95 kDa lipoprotein receptor, 
in a in a sort of "piggy-back" transport system, to gain entry to the yolk (Fig. 6.1). 
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6.2 Methods 
6.2.1 Dephosphorylation of RfBP 
The method used was that of Rhodes et al. (1959). 1.5 ml of a2 mg/ml RfBP solution 
was dialysed against 0.05 M sodium acetate, pH 5.3. The dialysis tubing was then 
placed in a universal tube filled with 30 ml of buffer, at 37C. 15 ýtl of potato acid 
phosphatase (0.9 units) (Boehringer Mannheim, grade 1) was added to the RfBP solution 
in the dialysis tubing, followed by an additional 5 gl (0.3 units) after 3 hours incubation. 
I ml of buffer (outside the dialysis bag) was removed from the universal tube and 
retained for inorganic phosphate determination. Further I ml samples were taken from 
the buffer at I hour intervals for the next 4 hours, and a final sample the following 
morning. 
The RfBP/phosphatase solution was removed from the dialysis sac and loaded onto a 
Whatman DE52 ion exchange column (I x8 cm, preswollen in buffer). The column 
was washed with 0.05 M sodium acetate buffer, pH 7, until the A280 of the effluent was 
equal to that of the buffer (the acid phosphatase is not retained by the column). The 
bound RfBP was eluted with buffer containing 0.5 M NaCl. For studies of refolding, the 
sample was freeze-dried and resuspended to a concentration of 10 mg/ml. 
6.2.2 Inorganic phosphate determination 
The samples taken from the buffer in the universal tube were tested for inorganic 
phosphate (released from RfBP by the acid phosphatase enzyme) (adapted from Ames, 
1959). 0.5 ml 2% ammonium molybdate and 0.5 ml 10% ascorbic acid (both in H20) 
were added to the I ml samples. A buffer blank was also prepared. The samples were 
56 
mixed well, boiled for 5 minutes, cooled (30 min) and the absorbance at 800nm 
recorded. A standard phosphate curve was produced, using 2.5 mM - 62.5 mM 
KH2Po4. The standards were treated in the same manner as the samples. 
6.2.3 Phosphate stain for SDS gels 
15 gl of dephosphorylated and native RfBP were subjected to SDS polyacrylamide gel 
electrophoresis, as previously described (Section 2.4). The gel was stained for the 
presence of phosphates, as described by Cutting (1984). The following reagents were 
prepared: 
A. 10% (w/v) sulphosalicylic acid in 25% 2-propanol 
B. 0.5M CaC'2 in 10 % sulphosalicylic acid 
C. 0.5M NaOH 
D. 1% (w/v) ammonium molybdate in deionised water 
E. 1% (w/v) ammonium molybdate in IN HN03 
F. 0.5% methyl green in 7% acetic acid 
G. 10% (w/v) sulphosalicylic acid 
H. 7% acetic acid 
SDS gels were fixed in A for 12hr, or overnight, with frequent changes of fixer. The 
gel was fixed in B for I hr, and then rinsed thoroughly in H20 (to reduce background). 
The gel was then placed in C, preheated to 60'C, for 30 min, then rinsed 2x 10 min 
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in reagent D. The gel was then placed in E for 30 min, then stained in F for 30 min. 
The gel was clestained in G, at 60'C. The destained gel was stored in H. 
6.2.4 Characterisation and refolding of dephosphorylated RfBP 
The dephosphorylated protein was run on an SDS polyacrylamide gel alongside native 
protein, and stained for protein. CD and fluorescence spectra of the dephosphorylated 
RfBP were recorded (Sections 2.2.1 and 2.3.1). The riboflavin binding ability of the 
dephosphorylated protein was ascertained (Section 2.8). 
6.2.4.1 Refolding of denatured dephosphorylated RfBP 
The dephosphorylated RfBP was denatured as before (Section 4.2.1). The refolding 
process was studied in the presence and absence of riboflavin, using both steady state 
and stopped-flow instrumentation. 
6.2.5 ANS as a probe for structural changes in dephosphorylated lIfIll' 
The interaction between denatured, refolding and folded dephosphorylated RfBP was 
studied, as described in Section 4.2.3. 
6.3 Results 
6.3.1 Dephosphorylation of RfBP 
On average, after dephosphorylation and separation from the phosphatase enzyme, the 
process yielded approximately 55 ±5% RfBP. 
The values obtained for the phosphate standard curve can be seen in Table 6.1, and in 
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Figure 6.2. The inorganic phosphate determinations on the samples of buffer removed 
during the phosphatase incubations can be seen in Table 6.2 and Figure 6.3. 
6.3.2 SDS Gel analysis 
The native protein was tested positive for the phosphate stain, while the 
dephosphorylated protein did not stain. When both versions of the protein were stained 
with Coomassie reagent, the dephosphorylated protein, had ran slightly further on the 
gel, corresponding to a loss of mass. 
6.3.3 Spectroscopic analysis 
The CD spectrum of dephosphorylated RfBP was slightly different from the native 
spectrum (Fig. 6.4). CONTIN procedure analysis (Provencher and Glbckner, 1981) 
revealed a reduction in the (x-helical content. The fluorescence spectrum for 
dephosphorylated RfBP was virtually identical to the native spectrum (Fig. 6.5). Tile 
dephosphorylated enzyme bound riboflavin in a 1: 1 ratio, in an identical fashion to the 
native protein (Fig. 6.6). The dephosphorylated protein appeared to unfold in a similar 
manner to the native protein (Figs. 6.7,6.8). 
6.3.4 Refolding of dephosphorylated RfBP 
6.3.4.1 Protein fluorescence and ribonavin binding 
Using manual mixing with the Perkin Elmer LS 50 instrument, the pattern of refolding 
was identical to that of the native, with a very long slow phase taking over an hour to 
completely regain protein fluorescence (Fig. 6.9). 
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Table 6.1 Absorbance values for phosphate standards. 
Phosphate (nmole) A800 
2.5 0.004 
12.5 0.070 
25.0 0.173 
37.5 0.266 
50.0 0.366 
62.5 
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Figure 6.2 Standard curve for free phosphate estimation 
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Figure 6.3 Enzymatic release of phosphates from apo-REBP 
using potato acid phosphatase 
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Figure 6.5 The fluorescence spectra of native and 
dephosphorylated M3P 
300 320 340 360 380 400 
100 
80 
60 
con 
40 
20 
0 
Molar ratio (R: flBP: Rf) 
Fig 6.6: The quenching of riboflavin fluorescence upon 
binding to dephosphorylated REBP. 
0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 
Figure 6.7 Changes in the CD spectrum of 
dephosphorylated RfBP after incubation in 0-6 
M Gdn HCI 
ri) 
1: ) m m m m 
.7. 
1 
1 
1ý 
'U 
1 
m 
1 
'D 
0- 
C) 0 0 
u) ti) to In 
M :D :D :D 
m (D m ID 
0 
G) 0 0 0 Gl 
ýý 13 0 . cl 13 
7 Z Z Z Z 
2: 
ru 
m 
0 
6 
II ci 
I 
ru 
0 
0 
0 
0M Gdn HCI 
IM Gdn HCI 
300 ------ 2M Gdn HCI 
------ 3M Gdn HCI 
5M Gdn HCI 
-------- 6M Gdn HCI 
250 
200 
150 
to 
f I 
100 o 
% 
Of 
, 717 7 
50 1 
300 320 340 360 33 80 400 
Wavelength (nm) 
Figure 6.8 Changes in the fluorescence spectrum of 
dephosphorylated REBP after incubation in 0-6 M 
Gdn HCI 
140 
120 
100 
cn 80 
Q 
a4 60 
40 
20 
Time (sees) 
Figure 6.9 Fluorescence emission at 350nm. following 
dilution of Gdn HCI, in the presence and 
absence of riboflavin 
0 500 1000 1500 
The analysis of the refolding reaction of the dephosphorylated apo-protein, as measured 
by the stopped-flow instrument, indicated that it followed similar kinetics to those of 
the native apo-protein. 
6.3.5 ANS binding 
The pattern of ANS binding followed a similar pattern to that of native RfBP, as 
described in 4.3.3. It was noted, however, that the enhancement of ANS fluorescence 
upon binding the dephosphorylated protein was approximately 10% greater than the 
enhancement found with the native protein (Fig. 6.10). 
6.4 Discussion 
RfBP was readily dephosphorylated by the potato acid phosphatase, the inorganic 
phosphate analysis revealing that all eight phosphoserines were hydrolysed. The 
fluorescence spectrum was identical to that of the native protein, and the riboflavin 
binding ability is not affected by dephosphorylation. However the secondary structure, 
as estimated from the CD spectrum by applying the CONTIN procedure (Provencher 
and G16ckner, 1981) showed a marked decrease in (x-helix content. It is possible that 
the loss of these eight negatively charged groups, clustered together, leads to a change 
in local ionic interactions, causing a slight relaxation in the local secondary structure. 
From the fluorescence and binding analysis, however, it is clear that no gross overall 
structural change occurs upon dephosphorylation, and that the binding site is conserved. 
The kinetics of the refolding reaction for dephosphorylated RfBP, in the presence and 
absence of riboflavin, were found to be identical to that of the native protein. Likewise, 
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the kinetics for the regain of riboflavin binding activity by refolding and the native 
protein. It was thought possible that the cleavage of the phosphate groups may have 
had some effect on the refolding of RfBP in vitro, as with the loss of 8 negatively 
charge groups, the local ionic interactions could have been disrupted, or enhanced. 
Electrostatic attractions or repulsions could possibly reduce the vast number of 
conformations open to the random coil unfolded molecule. However, dephosphorylation 
had no effect on the refolding of RfBP. Taken together with the accessibilitY of the 
phosphate groups to the phosphatase enzyme, this suggests that the phosphates are 
located on the exterior of the protein, and that the phosphorylation occurs after folding 
has completed. 
It seems likely that the phosphates are involved in cross-linking the protein to 
vitellogenin, for "piggy back" transport into the yolk via the 95 kDa receptor 
(MacLachlan et al., 1994). All three forms of RfBP (white, yolk and serum) are able 
to bind equally well to vitellogenin (Maclachlan, et al., 1994). However, the rate of 
clearance of the white and yolk RfBPs from the blood (as opposed to uptake by tile 
developing oocyte) in tracer studies is much greater than for the serum protein (Miller 
et al., 1982a). This is probably due to the difference in carbohydrate structures, 
targeting the yolk and white for preferential uptake by the liver, from the bloodstream, 
for degradation (Miller et aL, 1982)(Section 7.1.2). 
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Chapter 7 Degl-vcosylation of RfBP 
7.1 Introduction 
Glycosylation is the most common and diverse post-translational modification undergone 
by proteins (Lis and Sharon, 1993). From higher organisms, to archaebacteria, the 
process is virtually ubiquitous. Almost all egg white proteins and blood serum proteins 
are glycosylated for example (Lis and Sharon, 1993). Glycoproteins can be found in 
the cytoplasm, the nucleus or be membrane-spanning (without exception, integral 
membrane proteins of higher organisms are glycosylated). Some bacteria, long thought 
to be unable to glycosylate proteins, have now been shown to possess the ability to form 
glycoproteins (Lis and Sharon, 1993). Although there is a relatively small number 
(around 10) of monosaccharides available, the structural variety possible is huge, with 
different linkages (i. e. cc or 0), anomeric stereochernistry, branching etc. 
Due to the fact that the carbohydrate structure is not dictated by the gene sequence, 
glycosylation can be tissue, or even cell, specific, leading to functional diversity from 
a single gene product. For example, HLA-DR antigen isolated from a human melanoma 
cell line and from a B-lymphoblastoid cell line, both originating from the same 
individual was found to be identical, except for the size of the carbohydrates and the 
extent of sialylation (Alexander et al., 1984). Also, the glycosylation of Asn 245 of 
viral surface glycoprotein El of Sindbis virus depends on the viral host- whether the 
virus is grown in chick embryo fibroblasts or Chinese hamster ovary cells 
interestingly, glycosylation of the other site (Asn 139) is unaffected by the cell-type 
(Hsieh et al., 1983). Tissue and cell specific glycosylation such as this has implications 
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for antibody recognition. 
The significance and function of glycosylation are only just beginning to be understood. 
Carbohydrates are thought to be involved with the removal of glycoproteins from the 
blood- the terminal sialic acid residue is removed by sialylases in the blood stream after 
a passage of time (Lis and Sharon, 1993). The exposed galactose residue is then bound 
to receptors on the membranes of liver cells, which causes them to be internalised 
(endocytosis) for degradation. Carbohydrates have also been implicated in cell-cell 
interactions, i. e. interactions between neural cell adhesion molecules (N-CAM) (Lis and 
Sharon, 1993). Glycosylation may also play a role in the stabilisation of protein 
structure, increasing their life span. Yeast invertase is produced as a number of 
isoenzymes, differing only in the extent of glycosylation (a greater degree of 
glycosylation, inparts greater resistance to degradation (Candy, D. J, 1980)). Also, over 
50% of monoclonal antibodies generated against animal cells and cell membrane 
proteins have been shown to recognise carbohydrates of surface proteins (Lis and 
Sharon, 1993). 
7.1.2 Glycosylation of apo-RfBP 
Hen egg white RfBP contains two complex carbohydrates N-linked to asparagines 36 
and 147 (Hamazume et aL, 1984)(Fig. I- 1). Although the carbohydrate composition is 
known, the structure has not yet been determined (Miller et al., 1982a). The main 
structural difference between the white, yolk and serum riboflavin binding proteins is 
found in the carbohydrate composition. Although the serum protein becomes the yolk 
protein upon uptake by the oocyte, significant differences in carbohydrate composition 
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have been found between them, suggesting that serum RfBP must undergo glycolytic 
modification during or after transport to the yolk (Miller et al., 1982a). The differences 
in carbohydrate composition were thought to be due to a carbohydrate -d i rec ted uptake 
mechanism, for the transport of serum RfBP to the yolk (Miller et a], 198 1). However 
tracer studies have shown this not to be the case (Miller et al., 1982a) When labelled 
serum, yolk and white RfBPs were injected into hens, it was found that the low 
proportions of white and yolk RfBP reaching the oocyte reflected preferential clearance 
from the plasma, rather than specific uptake of the serum protein. It seems likely that 
this is due to a hepatic receptor which recognises the terminal N-acetyglucosamine of 
the white (Miller et al., 1982a). The phosphates are currently thought to be involved 
in the uptake of serum RfBP into the yolk (discussed further in Section 6.4). 
7.1.3 Deglycosylation of RfBP 
A chemical method of deglycosylation was chosen for RfBP. The method of Edge et 
al. (1981) was adopted over the hydrogen fluoride (HF) technique, largely for safety 
considerations. This method involves the use of trifluoromethanesu I phonic acid at low 
temperature, followed by the neutralisation of the acid by aqueous pyridine, which has 
been found to be efficient in the cleavage of N-linked carbohydrates from proteins, 
without detriment to the native protein structure (Sojar and Bahl, 1987). 
This method has previously been applied to RfBP by Karande el al., (1991) who 
reported successful deglycosylation (as shown by lack of staining for carbohydrate on 
SDS PAGE gels), although they reported some possible denaturation of the protein. The 
neutralisation reaction between TFMS and pyridine is extremely exothermic, and 
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therefore, in the modified method employed, every effort was used to keep the reaction 
temperature at a minimum. The lack of staining for the presence of carbohydrates on 
gels was used as an indicator of successful deglycosylation. 
7.2 Methods 
7.2.1 Chemical deglycosylation of apo-RfBP 
The chemical deglycosylation method employed was modified from Sojar and Bahl 
(1987). 60 gl of toluene was added to I ml of trifluoromethanesulphonic acid (TFMS) 
and mixed gently. I mg samples of RfBP (1yophilised in a glass test tube) was placed 
on an ethanol/dry ice for 30 seconds. 150 gl of TFNIS/toluene solution was added very 
slowly to the protein, and the reaction mixture left on the ethanol/dry ice for 30 seconds, 
then transferred to a -20'C freezer for 10 mins. The samples were removed and shaken 
gently to aid melting. They were replaced in the -20'C freezer, and left for up to 4 
hours. The samples were then placed on ethanol/dry ice for 30 seconds. 450 ltl of 60% 
pyridine was added very slowly, and left to stand for 30 seconds, then transferred to dry 
ice for 5 minutes, then to an ice/water bath for 15 minutes. 1.5 ml of 0.5% ammonium 
bicarbonate was added to the test tube, and mixed. The solution was transferred to an 
Eppendorf tube, and the precipitate formed on ammonium bicarbonate addition was 
pelleted by centrifugation (15 mins). The supernatant was discarded, the pellet 
resuspended in I ml 0.5% ammonium bicarbonate, and dialysed against this solution, 
to remove the pyridine. The sample was then dialysed overnight against 0.05 M sodium 
phosphate buffer, pH 7.0. 
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7.2.2 SDS PAGE analysis of deglycosylated apo-RfBP 
The deglycosylated samples were ran on an SDS PAGE gel (Section 2.4), along with 
native RfBP. The gel was then stained for the presence of carbohydrate and protein 
(Coomassie Blue and silver staining) using the following methods: 
Carbohydrate Staining 
The carbohydrate stain procedure was that of Sargent and George (1975). 
Reagents: 12.5 % TCA 
Schiff's reagent 
0.5 % sodium metabisulphite 
5% acetic acid 
I% periodic acid/3 % acetic acid 
The gel was immersed in the TCA for 30 minutes, then rinsed in distilled ILO for 30 
minutes. It was then washed with the periodic/acetic acid solution for 50 minutes, then 
water overnight. The gel was stained by immersion in Schiff's reagent for 50 minutes 
in a dark room, and then washed with sodium metabisulphite (3 x 30 min) to remove 
excess stain, followed by an overnight immersion in water. The gel was stored in 5% 
acetic acid. 
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Silver Stain 
The silver stain procedure was adapted from that of Gottlieb and Chavko, (1987). The 
method was as follows: 
Reagents: 
Fixer - 50 ml methanol 
10 ml acetic acid 
10 ml 50 % v/v glycerol 
30 ml distilled H20 
Stain and development- A. 2% silver nitrate/2 % ammonium nitrate 
B. 10 % tungstosilicic acid 
C. 2.8 % v/v formaldehyde (n. b. commercial stock is 37 
D. 5% sodium carbonate (store at 4'C, use within 3 months) 
A, B and C are made w/w with distilled H20 
The gel was shaken gently in fixer for 20 minutes, and then in 200 ml of distilled 11,0 
twice for 10 min. The staining solution was prepared thus: - 17.5 ml distilled 1120 was 
placed in a beaker. 2.5 ml of each of A, B and C, were added in that order, while mixing 
rapidly. Then 25 ml of D was added to the beaker quickly, still mixing rapidly. 
The water was then decanted from the gel and the stain solution added. The gel was 
shaken gently until bands appeared (5-15 min). The staining reaction was stopped by 
placing the gel in 5% acetic acid. The gel was stored in the 5% acetic acid. 
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7.2.3 Characterisation of deglycosylated apo-RfBP 
The sample was subjected to CD and fluorescence analysis, as described previously 
(Sections 2.2.1 and 2.3.1) A riboflavin binding assay was also carried out on the 
deglycosylated sample (Section 2.8). 
7.3 Results 
7.3.1 SDS PAGE analysis of deglycosylated apo-RfBP 
Initially it appeared as if the deglycosylation of RfBP had been successful- upon 
staining of one half of the gel for carbohydrate, the native controls tested positive for 
the presence of sugars, while the lanes containing the deglycosylated sample were clear 
of staining. However, when the other half of the gel was stained for protein, the 
deglycosylated sample lanes did not stain. The absorbance of the deglycosylated sample 
at 280 nm indicated that there was protein present (although the absorbance at 3 10 nm 
was relatively high (approx. 25 % of the absorbance value at 280 nm). In an effort to 
visualise the protein on the gel, silver staining was used (approximately 100 times more 
sensitive to proteins than Coomassie Blue), but the result was still negative. 
7.3.2 Spectroscopic analysis of deglycosylated RfBP 
Surprisingly, given the apparent lack of protein from SDS PAGE analysis of the 
deglycosylated sample, the CD spectrum obtained from the deglycosylated sample was 
not too dissimilar from the native protein (Fig. 7.1). CONTIN secondary structure 
analysis (Provencher and Mckner, 1981) indicated a decrease in secondary structure. 
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Figure 7.1 The far UV CD spectra of native and 
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From the fluorescence spectrum (Fig. 7.2), the k.., was red-shifted to 354.5 ni-n, 
indicating a virtually complete tertiary structure loss. The intensity of the peak was also 
greatly reduced (>50 
The protein was unable to bind riboflavin (Fig. 7.3). 
7.4 Discussion 
Fluorescence and CD were employed to determine the conformation of the protein. 
Although different from the native RfBP spectra, these seemed to indicate that there was 
protein there, albeit lacking in some secondary and tertiary structure associated with the 
native. The treated RfBP also failed to bind riboflavin. The TFMS incubation times 
(15 min to 4 hr) and temperature of the pyridine neutralisation stage (-20 to -80T) were 
varied but an active deglycosylated RfBP was not produced. 
The fact that a CD spectrum (although with a decreased cc-helical content compared to 
native) was obtained, even although the Coomassie Blue stained gel seemed to suggest 
that there was no protein present, could indicate that the protein had fragmented into 
peptides big enough to form some structure, but small enough to have ran off the 
bottom of the gel. The TFMS neutralisation with pyridine is an extremely exothermic 
reaction, hence the need for precooling the reagents and maintaining a low reaction 
temperature. The speed of addition of the pyridine also played a part in this respect. 
Experimental observations demonstrated that in samples where the pyridine was added 
quickly, a brown precipitate was formed, and the resulting CD spectrum indicated that 
less secondary structure was present. Karande et al (1991), used the TFMS method of 
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deglycosylation on RfBP in an effort to determine the epitope of a RfBP monoclonal 
antibody they had developed. Although they reported that the Mab still recognised 
deglycosylated RfBP, through personal correspondence it was discovered that the treated 
RfBP was unable to bind riboflavin, and that later conformation sensitive Mabs did not 
recognise the treated RfBP. The epitope for the Mab that recognised the 
TFMS/pyridine treated RfBP was later determined to be the C-terminus, revealing that 
it is exposed on the surface of the protein (Velu et aL, 1992). As it is known that 
TFMS is a strong denaturant (Manjunath and Sairam, 1984), and given the extreme heat 
generated by the pyridine addition, coupled with the highly acidic environment, it is 
highly likely that chemical deglycosylation of RfBP using the Sojar and Bahl method 
results in denaturation and/or fragmentation of RfBP, and therefore this method is 
unsuitable for the production of deglycosylated RfBP in which the integrity of the 
polypeptide chain is preserved. 
Some refolding studies on mammalian proteins that have been expressed in E. coli 
(which lack the necessary cellular machinery for glycosylation) have suggested that the 
absence of carbohydrates has no effect on the kinetics of successful folding (Freedman, 
1992). The absence of carbohydrate groups, with the resultant change in solubility, 
however, may promote the aggregation of folding proteins. Yeast invertase is non- 
glycosylated in the cytoplasm, but the secreted protein undergoes glycosylation. 
Refolding studies have shown that at low concentrations, both forms of the protein will 
rcfold to a give a similar yield (Schulke and Schmid, 1988a, b). At higher 
concentrations, however, the cytoplasmic (non-glycosylated) protein forms aggregates. 
This can explain the disruption of protein secretion sometimes found upon the 
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perturbation of glycosylation (i. e. by tunicamycin, an antibiotic) (see Freedman, 1992, 
and references therein). Instead of the carbohydrates acting as a targeting signal, it is 
more likely that the nascent proteins aggregate, thus forming no product for secretion. 
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Chapter 8 General Discussion 
8.1 Summary of results 
Riboflavin binding protein was purified from domestic hen egg white. The purified apo- 
protein had identical CD and fluorescence spectra to those previously obtained, and 
bound riboflavin in a 1: 1 molar ratio. The protein was found to be fully unfolded in 6 
M Gdn HCI, with a complete loss of secondary and tertiary structure, and riboflavin 
binding ability. The unfolded protein was found to refold rapidly on the removal of the 
denaturant. The secondary structure of the protein (as measured by far UV CD) was 
completely regained within approximately 12 msec (the dead-time of the stopped-flow 
instrument in CD mode). The regain of tertiary structure of the protein (as measured 
by protein fluorescence) was resolved into 4 main phases, namely very fast, fast, slow 
and very slow. 80% of the protein fluorescence was regained within 2 msec (the dead- 
time of the stopped-flow instrument in fluorescence mode). The fast phase involved the 
regain of approximately 10% of the protein fluorescence (t,, = 25-35 msec), while the 
slow and very slow phases both represented approximately 5% of the total protein 
fluorescence regain, with half-times of 46 seconds and I hour respectively. Tile 
presence of riboflavin has no effect on the early stages of refolding, although it seemed 
to impede the acquisition of the final 5% of tertiary structure. The binding of riboflavin 
by the native protein was found to be very fast, with a half-time of approximately 3.5 
msec. The refolding RfBP was able to bind riboflavin quickly (t,, = 30 mscc) after the 
start of the refolding reaction, showing that the formation of the riboflavin binding 
pocket corresponded with the fast phase of refolding. 
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RfBP was found to bind ANS, resulting in a 20-fold enhancement of the ANS 
fluorescence. Both the apo and holo forms of the protein were able to bind ANS, but 
the unfolded protein was not. The binding of ANS to RfBP led to a quenching of the 
protein fluorescence (by 50%), and a2 nm blueshift in the emission maximum. The 
refolding protein was found to regain ANS binding ability within the very fast phase 
(within the instrument dead-time) i. e. before the formation of the riboflavin binding site. 
The presence of ANS (20 gM) had no effect on the kinetics of refolding. 
RfBP contains 9 disulphide bridges. The apo-RfBP was reduced. In reoxidising 
conditions, the reduced protein failed to spontaneously reoxidise, instead forming 
random, non-native disulphide bonds. However, when protein disulphide isomerase was 
present, in excessive amounts, up to 50% successful reoxidation of RfBP was achieved. 
The presence of PDI from the start of the reaction, and low temperatures (4'C) were 
necessary for this reaction. 
The protein contains 8 phosphorylated serine residues. A dephosphorylated protein was 
produced using acid phosphatase. The dephosphorylation was shown to be complete. 
The dephosphorylation appeared to cause very little change to the secondary and tertiary 
structures of RfBP. Dephosphorylation had no effect on riboflavin binding or on the 
refolding reactions. 
Attempts to deglycosylate RfBP using TFMS were unsuccessful. It is thought that the 
highly exothermic nature of the reaction causes the protein to fragment. 
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8.2 Unfolding 
Guanidinium chloride was found to readily denature RfBP, as has been found in other 
protein systems (see Jaenicke, 1987, and Creighton, 1990 and references therein). In 
6M Gdn HCI, RfBP exhibits all the characteristics of a random coil. Although the 
protein was always incubated in Gdn HCI for 15 minutes, the denaturation was very 
rapid (results not shown), at least within the dead-time of the steady state instrument. 
The process, as noted previously (Allen et al., 1992), was not a simple two-state process 
(Section 4.3.1.2, Fig. 4.4). There appear to be two phases (0-2 M and 5-6 M Gdn HCI) 
where most of the changes in secondary and tertiary structure occur; a stable semi- 
unfolded intermediate is found between 2 and 5M Gdn HCI. This is especially 
apparent from. the fluorescence data, which indicates that the tertiary structure is almost 
constant between 2 and 5M Gdn HCI- 
A similar situation has been found with other proteins e. g. Hen egg white cystatin 
follows a similar pattern (Bj6rk, 1992). In this case it was suggested that the 
intermediate stage represents a situation where a distinct structural element of the 
protein with a lower stability has been denatured independently, preceding the global 
unfolding of the protein. From the 3-dimensional structure available for hen cystatin, 
a region which could fit this hypothesis is present; a slightly flexible tight turn is present 
between residues Pro-72 and Met-89 - this region is visibly independent from the main 
body of the protein. Unfortunately, detailed structural information is not yet available 
for RfBP, so similar designations of structurally exposed/accessible regions cannot be 
made. 
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Other studies have noted the difference in extent of loss of secondary and tertiary 
structure, and activity of proteins, upon Gdn HCI denaturation (Tsou, 1986), in 
particular the increased susceptibility of activity/binding as compared to the overall 
secondary and tertiary structural features. 
This is noted in RfBP, as the protein has lost all riboflavin binding ability by 2.5 M 
Gdn HCI, when a large proportion of secondary and tertiary structure is still present. 
It has been suggested that active/binding sites are situated in regions of the molecule 
more susceptible/accessible to denaturants; this would correspond to the exposed turn 
in cystatin. It is also highly possible, indeed likely, that the small changes in secondary 
and tertiary structure observed at low concentrations of Gdn HCI are enough to perturb 
the conformation of a highly structured site to a sufficient extent that specific 
interactions contributing to binding are lost. This slight but significant conformational 
change could be as a result of local denaturant activity, or part of a wider denaturant 
induced conformational transformation. The second possibility is indeed likely in the 
case of RfBP as the extremely tight binding of riboflavin is facilitated by several 
specific interactions between RfBP and the riboflavin molecule (Fig. 3.5). 
8.3 Refolding 
8.3.1 CD - regain of secondary structure 
The refolding of Gdn HCI denatured RfBP was initiated by the dilution of the 
denaturant; this reaction was very rapid. Stopped-flow instrumentation was employed 
in order to attempt to resolve the refolding processes. All of the secondary structurc 
had been regained within the dead-time of the instrument in CD mode (approx. 12) 
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msec). This is comparable to a number of sYstems studied in this fashion where all, or 
a large proportion of the secondary structure is formed at a very early stage of refolding, 
within the dead-time of the stopped-flow instrumentation used (Elbve et al., 1992; 
Kuwajima et al., 1987; Kuwajima et al., 1988). From these and other similar studies, 
it is apparent that the very rapid formation of secondary structure is a common feature 
in the folding of globular proteins. In fact, techniques which go beyond the time 
limitations of stopped-flow CD have indicated that helix formation can be extremely 
rapid. Refolding of short peptide sequences (which have been shown to be able to 
adopt native or near-native secondary structure in solution) have been used with 
methods such as temperature jump, electric field jump and resonant ultrasound, to study 
helix fon-nation on a nanosecond time scale- this has been shown to occur in less than 
160 nanoseconds (Williams et al. 1996). Temperature jump experiments have been 
carried out on barstar. Some proteins are cold-labile; at 2'C, barstar is unfolded, but a 
return to ambient temperature causes the protein to refold (N61ting et al., 1995). This 
temperature jump can be achieved with a laser; a rapid phase of 3 100 s*' is observcd 
when the cold-denatured barstar is temperature-jumped from TC to I OT in about 8psec. 
This very rapid process involves only a small change in free energy and modcst 
structural compaction. The compaction is followed by the major folding transition at 
8 s', detected from conventional stopped-flow techniques (N61ting et al., 1995). 
There is still some debate over the nature of the very early phases of protein refolding. 
These have been thought to be the formation of elements of local secondary structure 
which may act as nucleation sites for a much wider secondary structure formation and 
resultant hydrophobic collapse into a reasonably compact state (Mann and Matthews, 
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1993) However, recent studies have suggested that a non-specific hydrophobic collapse 
can precede any native secondary structure formation (Agashe et al. 1995). These 
processes are clearly too rapid to be measured by conventional rapid mixing techniques 
employed here. 
8.3.2 Fluorescence - regain of tertiary structure 
The refolding of RfBP as monitored via the regain of protein fluorescence revealed 
more of the early stages of tertiary structure acquisition. In common with other 
fluorescence studies, the regain of protein fluorescence consisted of a combination of 
fast and slower phases (Elbve et al., 1992; Semisotnov et al., 1987). Approximately 
80% of the protein fluorescence had been regained within the dead-time of the stopped- 
flow instrument in fluorescence mode (< 2 msec), with only the final very slow phase 
taking up to 2 hours. The regain of riboflavin binding ability, which is the best 
indicator of successful folding, is rapid, coinciding with the fast phase (Table 4.4). This 
indicates that the tertiary structure at this point is very near native - the final 10% of 
fluorescence still to be regained at this point can only account for very minor structural 
changes which do not have any significant effect on binding ability. 
The fact that ANS can bind to the site/sites to which it adheres at such an early stage 
(< 2 msec), appears to indicate that ANS binding seems to be a good test of native-like 
structure, which is formed very quickly. Although the ANS binding studies did not 
follow the classic pattern of rapid binding and slow release that would indicate the 
formation of a molten globule as an early intermediate in the refolding pathway, at its 
subsequent decay, the structure of RfBP at this point must somewhat resemble the 
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molten globule. The fact that ANS is not released from the refolded protein, merely 
confirms that the native RfBP molecule has ANS binding capability i. e. that 
hydrophobic sites/environments are present in the native molecule, and not just during 
refolding. Thus in this case, the apparent negative test for a molten globule state is 
meaningless. From this compact, condensed state, the number of possible conformations 
that the molecule has to explore to reach the native state is greatly reduced. This state 
can be said to be as good as reached upon the regain of riboflavin binding ability, after 
approximately 70 msec. 
8.3.3 Slow phases in protein refolding 
As has been discussed, with the optimisation of stopped-flow technology for the 
acquisition of CD and fluorescence changes on a very short time-scale, much of the 
recent work on protein refolding has focused on the initial very fast phases of the 
refolding reaction. However, it should not be forgotten that in virtually all proteins, for 
which the refolding process have been studied, folding proceeds via a slow stage, and 
that this stage, although probably much smaller in proportion to the changes observed 
in the fast phases, does still represent a real and measurable structural change. 
The main process responsible for the long slow phases often observed in protein 
refolding is thought to be the isomerisation of X-Pro imide bonds (Nall, 1994). 
Although it is possible for the amide linkage to take either a cis or trans conformation, 
the trans form is highly favoured, and the cis is extremely rare (the trans: cis ratio is 
about 100-1000 to I in an unfolded polypeptide chain, and almost non-existent in native 
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protein molecules). Proline is the exception however; instead of an amide bond, they 
are linked by an imide bond to the preceding residue. While the imide bond still has 
a preference for trans linkages, in an unfolded structure the equilibrium distribution is 
30% cis and 70% trans (Brandts et aL, 1975), and while still not common, cis imide 
linkages are found more frequently in native proteins than cis amide links (about 6 
of imide linkages are in the cis conformation (see Mucke and Schmid, 1992, and 
references therein)). 
When a native protein is unfolded, any cis X-Pro linkages are more than likely to 
assume the trans conformation (the 30: 70 split). Upon refolding, the polypeptide chain 
must have the correct X-Pro linkages to be able to assume the native conformation. If 
the imide bond exhibits the incorrect stereochemistry then it must undergo isomerisation 
before the refolding reaction can be completed, and the final, native tertiary structure 
assumed. 
It was first proposed by Brandts et al. (1975) that the rate-limiting step in protein 
refolding was the cis-trans isomerisation of non-native proline peptide bonds; and that 
the slow phase in protein folding was due to a sizeable proportion of the refolding 
molecules having proline residues in the incorrect conformation. In some of the most 
commonly studied refolding systems, RNase A, ribonuclease TI and thioredoxin all 
have at least one cis imide linkage, while lysozyme and cytochrome c have all trans 
linkages. The refolding kinetics of those with cis linkages all contain slow stages, while 
the pathways of those with all trans involve predominantly fast kinetics. 
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Given that the half-life of proteins in vivo in many cases can be shorter than the length 
of some slow phases found in protein refolding (i. e. > 30 minutes), it was likely that a 
system existed in vivo to facilitate the catalysis of cisltrans proline isomerisation. 
Peptidyl prolyl cis-trans isomerase (PPIase) was first purified by Fischer et al., (1984) 
from porcine kidney. It was shown to catalyse the isomerisation of proline imide 
pepticle bonds in oligopepticles, and later in a number of studies on protein refolding, 
in which slow folding phases had been observed (Lang et al., 1987). In various proteins 
whose refolding involve slow phases, the rates of these phases have been considerably 
increased by the action of PPIase (Schbnbrunner et al., 1991a; Mucke and Schmid, 
1992), demonstrating that slow phases observed in protein refolding are due solely to 
cisltrans proline linkage isomerisation (Lang et al., 1987). 
PPlase activity has been associated with the lumen of the ER (as well as the cytosol), 
the cellular compartment where folding occurs (Bose and Freedman, 1994). This 
compartmental isation would localise PPlase along with PDI (Section 5.1.3) the other 
catalyst of protein folding. In vitro studies have shown that the presence of PPlase 
greatly increases the efficiency of PDI (Sch6nbrunner and Schmid, 1992). It is very 
possible that the two 'foldases' act in conjunction with each other, or are even mutually 
interdependent on each other (Schbnbrunner and Schmid, 1992) (i. e. the isomerisation 
of imide linkages into their native conformation improves accessibility, or presents a 
more attractive site of action for PDI, and the formation of the correct disulphide 
linkages plays a similar role for PPIase activity. ) 
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8.4 The effect of post-translational modifications on the refolding of RfBP, and 
relevance to in vivo folding 
Of the post-translational modifications that were originally planned to be studied in this 
project, disulphide bond formation, and phosphorylation were investigated, while 
attempts to deglycosylate RfBP were unsuccessful. Given that the refolding of reduced 
RfBP was only possible in the presence of PDI, and the large number of disulphide 
linkages in RfBP, it does seem almost certain that PDI has a role in the in vivo folding 
of RfBP. The high concentration of PDI necessary for a reasonable level of successful 
reoxidation (to a native-like state) is consistent with the high levels of PDI present in 
the lumen (thought to be in the millimolar range). 
Dephosphorylation of RfBP seemed to have absolutelY no effect whatsoever on the 
refolding kinetics of RfBP. Although it might have been expected that the removal of 
eight, closely grouped negatively charged groups might have had some effect on the 
refolding protein (e. g. through reduced electrostatic interactions), this was not found. 
The phosphorylated serines are found towards the end of the polypeptide chain, and the 
accessibility of the phosphates to phosphatase suggests that they are on the outside of 
the molecule; it could be that this portion of the protein is only really involved in the 
folding process towards the end of the reaction, and has little interaction with the rest 
of the molecule. Certainly, the fact that, in vivo, phosphorylation probably occurs after 
folding has been completed, would imply that phosphorylation does not play a crucial 
role in determining the protein folding process. 
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8.5 Future work 
The fast phases of the refolding process have been well characterised in this study. The 
slow and the very slow phases observed are thought to be due to uncatalysed cis1trans 
proline isomerisation. RfBP has 8 proline residues. To verify whether any of them 
exist in the cis conformation, a high resolution 3-D structure of RfBP would be 
required, and to date, this information is not yet available. If the rate of the 2 slow 
phases were increased by refolding in the presence of PPIase, then this would confirm 
the proline isomerisation theory for the slow phases. Although the amplitude of these 
phases is small, and a change in the kinetics of these might be hard to detect, the effect 
of PPIase can be quite significant (Lang et al., 1987; Sch6nbrunner et al. 1991). It is 
hoped that a sample of PPIase will be obtained in the near future, and that this 
experiment will be undertaken. 
A 3-D structure for RfBP has still not been resolved. Zanette et al. (1984) reported 
obtaining crystals; unfortunately these did not diffract sufficiently, and attempts at 
producing isomorphous replacements were unsuccessful (personal correspondence with 
L. Sawyer). A detailed structure would surely provide greater insights into the refolding 
of RfBP (conformation of imide links etc. ), and also the mode of binding of riboflavin 
to Rfl3P, with the resultant quenching of riboflavin fluorescence. 
The deglycosylation of RfBP by chemical means (TFMS acid) was unsuccessful. Future 
attempts to deglycosylate RfBP could involve the use of endoglycosylases, which 
enzymatically cleave carbohydrates from polypeptides. Deglycosylated RfBP produced 
through enzyme action could be used to investigate the role of glycosylation in the 
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refolding of RfBP. 
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Appendix I 
Estimation of the Dead-time for the Stopped-flow Instrument 
The estimation of the dead-time of the SX. 17MV stopped-flow spectrophotometer was 
performed as according to Tonomura et A (1977). Their method uses the colour 
change induced by the reduction of 2,6-dichlorophenolindophenol (DCPIP) by L- 
ascorbic acid. 
The following solutions were prepared: 
i) Hydrochloric acid (0.02 M)/sodium chloride (0.2 M) 
100 ml of 0.1 M HCI + 5.8 g of NaCI diluted to 500 ml with double 
distilled H. O. 
ii) DCPIP (500 gM) 
14.5 mg of DCPIP dissolved in 10 ml of propanol 
1.16 g NaCI diluted to 100 ml with double distilled H20- 
iii) Stock ascorbic acid solution (200 mM) 
3.52 g ascorbic acid diluted to 100 ml with HCI/NaCl solution. 
iv) Working ascorbic acid solutions 
Working solutions of 5,10,20,50 and 100 mM were prepared from the 
stock solution by dilution with the HCI/NaCl solution. 
With the instrument in absorbance mode, the absorbance change at 524 nm was 
measured over 50 msec. The reaction was followed with the mixing in 1: 1, and the 
1: 10 mode (the concentration of ascorbic acid (in the small syringe) was increased). 10 
traces were averaged, and the kinetic data at each concentration was analysed. Data 
analysis was resticted to data collected from 2 msec after the triggering of the machine. 
The dead-time for each reaction was calculated using the reaction : 
td In (XtjXobs) 
I 
1/2 In 2 
where td= dead-time, 
t1r2 = half-time 
Xtot = theoretical total initial absorbance 
XObs = observed initial absorbance 
For 1: 1 mixing, the dead-time was found to be 2.045 msec ± 0.114 (n= 10), and for the 
1: 10 mixing (used in refolding reactions), 1.733 msec ± 0.176 (n= 10). This was found 
to correspond reasonably with the manufacturers' estimates (1.34-1.37 msec). 
The dead-time for the instrument in CD mode was not calculated due to hardware 
difficulties. However, the manufacturer estimates that the dead-time for the instrument 
in CD configuration (1: 10 mixing) is approximately 12 msec. The longer dead-time 0 
(compared to the instrument in absorbance/fluorescence mode) is due to the different 
dimensions of the CD cell. 
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